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Next generation sequencing (NGS) is a technology that advances our knowledge of 
human medical genetics with unprecedented amount of data. This vast amount of data 
presents challenges to existing statistical methods.  In this dissertation, I present three 
studies that demonstrate methods for efficiently analyzing NGS data using both simulated 
and real data.  
 
In the first study, I develop a method to tackle ancestry inference using small amounts of 
sequence data. In comparison to microarray experiments, sequencing data produce more 
uneven coverage and genotypes with higher error rates than those traditionally used for 
principal components analysis (PCA) of genetic ancestry. I overcome some of these 
challenges using a new statistical method that models sequence data directly, using both 




method achieves high accuracy in simulated data based on the Human Genome Diversity 
Panel as well as in a targeted sequencing study of age related macular degeneration. I 
show that inferred ancestry information helps address the population stratification 
problem. In our age-related macular degeneration study, our approach helps discover a 
high-risk rare variant in the Complement 3 gene.  
 
In the second chapter, I develop a model-based ancestry inference method that improves 
upon previous the work described in the first study. It is based on a likelihood-based 
model of ancestral location, using sequencing data as input. Without losing accuracy, it 
increases computational efficiency. For each sample, a parallelizable optimization 
algorithm can infer ancestry using a fraction of the computational resources required for 
PCA-based methods such as the approach in the first study. Evaluation using in the 
Human Genome Diversity Panel and another age related macular degeneration data set 
demonstrates its accuracy and efficiency. 
 
In the final study, I develop an improved genotype call method for low-coverage 
sequencing data. As high quality reference panels grow, it is helpful to incorporate these 
into genotype calling of new samples.  Using a coalescent based simulation and real data 
from the 1000 Genomes Project, I evaluate the utility of my method (which uses a panel 
of previously sequenced samples) to improve analyses of samples sequenced at various 
depths. The improvement in accuracy and computation time will be measured as a 
function of reference panel size. This work will be useful to investigators undertaking 




Chapter 1 Introduction 
Next Generation Sequencing (NGS) has been revolutionizing genetic research. Compared 
to the previously popular automated Sanger sequencing, NGS provides accurate genetic 
information in a faster and inexpensive way (Metzker 2009). This fundamental advantage 
enables broad NGS applications including categorizing human genetic variants (The 1000 
Genomes Project Consortium 2010; The 1000 Genomes Project Consortium et al. 2012), 
identifying functional elements in the genome (Birney et al. 2007), analyzing epigenetic 
markers  (Simonis et al. 2006),  studying genetic mutations responsible for cancer 
(McLendon et al. 2008) and classifying genetic materials gathered from the environment 
(Tringe et al. 2005).  
Importantly, genetic association studies also benefit from NGS technology. A crucial 
advantage of NGS technology is that it enables discovery of rare variants, which are 
usually not accessible in array-based studies (Cirulli and Goldstein 2010).  While most 
GWAS findings are common variants, and these variants explain a modest fraction of 
genetic heritability, it has been proposed that some of the “missing heritability” may be 
found among rare variants with large effect sizes (Manolio et al. 2009; Cirulli and 
Goldstein 2010). NGS studies, which do rely on lists of pre-existing variants, provide one 





Although NGS technology is appealing, its cost is a barrier to many experiments.  As of 
today, the rough cost of sequencing one genome is about $2,000 to $3,000 (Mardis 2011; 
Wetterstrand 2014). To study rare variants in population-based association studies, it is 
usually necessary to recruit thousands of samples to reach high statistical power (Li and 
Leal 2009), translating into multi-million dollar costs for each study. This dissertation 
explores statistical approaches to reduce sequencing costs.     
One cost-effective sequence-based experimental design is to utilize public controls to 
reduce the total number of genomes to be sequenced. The idea of using public controls 
has been widely applied in epidemiology studies (Shu et al. 1988; Becerra et al. 1990; 
Wolk et al. 1998). In genetic association studies, a prominent example of using public 
controls is the Wellcome Trust Case Control Consoritum (WTCCC) (Burton et al. 2007). 
Their design includes 14,000 cases of seven diseases and 3,000 shared controls from 
across Britain, and the analysis reveals 24 association signals. In other association studies, 
it is also not rare to see the use of shared controls (Zaykin and Kozbur 2010; 
Berthoumieux et al. 2013; Chen et al. 2013).  
In genetic association studies, rigorous analysts need to consider the population 
stratification to avoid spurious association signals. For example, in WTCCC studies, 
controlled the extent of population stratification problem by excluding non-European 
samples (Burton et al. 2007). Formally speaking, sample population is commonly treated 
as a confounding factor (Devlin and Roeder 1999; Pritchard and Rosenberg 1999; Price 
et al. 2006). To detect the true signals, which are associated with disease, it is important 




One approach to the population stratification problem is to infer ancestral locations of 
recruited samples using their genetic data and then adjust their locations in statistical 
models. Since the early days when microsatellite markers were popular, it is an 
interesting question to use genetic data to infer ancestry information (Menozzi et al. 1978; 
Sforza and Bodmer 1999; Rosenberg et al. 2002). Currently, single-nucleotide 
polymorphism (SNP) data is prevailing and there are a variety of ancestral inference and 
association analysis methods. In structured association analysis, ancestral locations are 
classified to subpopulation clusters and subsequent association analysis can be performed 
using stratified regression models (Pritchard et al. 2000b; Alexander et al. 2009). In 
Principal Components Analysis (PCA), principal components explaining much of the 
variation are used as covariates in analyses (Novembre et al. 2008; Novembre and 
Stephens 2008). Often, using just a few  top principal components as covariates in a 
regression model can control the population stratification problem (Price et al. 2006). 
Another approach to the population stratification problem is to model individual 
relationships. For example, in linear mixed model, the population is a random effect. This 
approach includes EMMA (Kang et al. 2008) and FASTA (fast association score test–
based analysis)(Chen and Abecasis 2007). These methods are appealing as they usually 
not only adjust for population, but also handle cryptic family structure. As linear mixed 
model are computationally intensive, there are several computational improvements such 
as EMMAX (Kang et al. 2010), GEMMA(Zhou and Stephens 2012), Fast-LMM (Lippert 
et al. 2011) and GRAMMAR-Gamma(Svishcheva et al. 2012).  
It is worth noting that the above methods rely on genome wide genetic data and often 




the majority of sequence reads cover a small fraction of the genome. As genome wide 
genetic markers are unavailable, these existing methods cannot be directly applied. . 
To solve this problem, in Chapter 2, I present an ancestral inference algorithm (jointly 
developed by Chaolong Wang) and apply it to a targeted-sequencing study of the Age-
related Macular Degeneration (AMD). Inferred ancestries are used to match AMD cases 
to additional controls. This method increases power, especially since the original design 
has highly unbalanced AMD case and control counts. Using this matched data set, I 
discover a rare coding variant (K155Q) that is associated with the AMD disease. 
In Chapter 3, to improve computation efficiency while maintaining inference accuracy, I 
develop a likelihood-based ancestral inference method. Although the algorithm described 
in Chapter 2 provides adequate accuracy in ancestry-aware association analysis, it 
requires demanding computation resources, which can be prohibitive in large studies. 
Therefore, I develop an alternative likelihood model-based method. This method has 
higher computation efficiency as well as higher accuracy. I conduct simulations and use 
real targeted-sequencing data to demonstrate its advantages.  
In Chapter 4, I tackle another challenging aspect of sequence analysis by evaluating the 
utility of imputation methods that integrate information from external reference panels in 
the analyses of sequenced samples.   
Imputation can infer genotypes at untyped locations and can improve the statistical power 
in genome wide association scan (Li et al. 2009b; Marchini and Howie 2010). Typical 
imputation methods will use densely genotyped haplotypes from a reference panel to 




GWAS chips usually include less than one million markers, researcher can use external 
reference panels, such as the HapMap Project (Gibbs et al. 2003) or the 1000 Genome 
Project (The 1000 Genomes Project Consortium 2010), to infer the genotypes that are not 
designed on GWAS chips. Using imputation to incorporate external information  has 
become a common practice in GWAS studies (Cantor et al. 2010; Nalls et al. 2011). 
However, in sequence studies, uses of external information have not been well studied. 
Unlike genotype array data, missingness in the sequence data is usually due to the lack of 
enough sequence depth (Li et al. 2011). As the cost of sequencing experiments is not 
negligible, the low-coverage sequencing design remains attractive, and it is therefore 
important to understand how to obtain accurate genotypes (Li et al. 2011). In current 
sequence studies, imputation methods are often applied without using reference panel 
(The 1000 Genomes Project Consortium 2010; Nielsen et al. 2011). Although Pasaniuc et 
al. 2012 demonstrated that the imputation methods can be applied on sequence data using 
external reference panels, but they did not provide details on variant discovery and 
genotyping accuracy.  
Therefore, in Chapter 4, we conduct a quantitative approach to evaluate the relationship 
between imputation panel and genotype calls in a systematic way, with a focus on the 
potential benefits of very large reference panels. We expect the reference panel to imply 
variant sites and thus increase the chance to discover and genotype variants of sequenced 
individuals. To evaluate this method, we have used coalescent simulation and the 1000 
Genome Project data. Our evaluation uses a fixed amount of test samples as a sequence 




panel of increasing size. Both simulation and real data support our findings that a large 
reference panel can improve genotyping of sequence samples.  
Overall, these three methods hint at promising new directions and can be directly applied 
to genetic research using sequence technology. These methods are highly efficient and 
therefore can handle very large sequence data sets.  Our AMD study discovered that a 
rare variant with high effect size can increase disease risk.  Imputation-based methods 
utilizing large reference panels can produce more accurate genotype calls through well-




Chapter 2 Ancestral inference and its application to age-related 
macular degeneration 
2.1 Introduction 
Age-related Macular Degeneration (AMD) is a leading cause of blindness among the 
elderly (Priya et al. 2012; Ratnapriya and Swaroop 2013). Over the past several years, 
genetic studies (Chen et al. 2010; Fritsche et al. 2013) of common variations have 
provided many clues about disease etiology. Due to assay limitations, these studies have 
typically ignored rare variants or examined them only in a small set of candidate regions. 
Here, we set out a targeted sequencing experiment to fine-map AMD susceptible loci to 
study the contribution of rare variants to disease risk. 
We initially conducted standard association analyses (Purcell et al. 2007; Chen et al. 
2010). Although several common variants can be replicated, we did not find new AMD 
variants with enough statistical evidence. Then we incorporated population controls from 
the NHGRI exome sequencing project (ESP). When augmenting this external data, we 
needed to avoid the population stratification problem which can happen if study samples 
come from heterogeneous populations. Therefore, we developed a statistical method that 
can efficiently estimate sample ancestries using sequence data such as targeted 
sequencing data. After that, we used a one-to-one ratio to match case (AMD cases) and 
control (AMD controls or ESP controls) samples that have the same population 




K155Q in complement 3 gene that associated with the AMD disease and replicated 
previous disease-associated variants in the targeted regions. 
This chapter is organized as follows: in Chapter 2.2, we describe a complete AMD 
genetic association study using target-sequencing data, which relied on the understanding 
of human ancestries; in Chapter 2.3, we detail the ancestral inference method and 
demonstrate the validity of the method using both simulation and AMD target-
sequencing data; in Chapter 2.4, we summarize the implications of our ancestry inference 
method for future next-generation sequence studies. 
2.2 Identification of a rare coding variant in complement 3 associated with age-
related macular degeneration 
TA slightly different version of his section has been published previously (Zhan et al. 
2013). 
Genetic and environmental factors contribute to age-related macular degeneration 
(AMD) (Swaroop et al. 2009; Priya et al. 2012), a major cause of vision loss in elderly 
individuals (Friedman et al. 2004).  Pioneering discovery of association of AMD with 
complement factor H (CFH (Edwards et al. 2005; Haines et al. 2005; Klein et al. 2005)) 
was quickly followed by the identification of additional susceptibility loci including 
ARMS2/HTRA1 (Jakobsdottir et al. 2005) and complement genes C3, C2/CFB and CFI 
(Gold et al. 2006; Maller et al. 2007; Yates et al. 2007; Fagerness et al. 2009). Genome-
wide association studies (GWAS) of AMD cases and controls have now revealed 
common susceptibility variants at ~20 different loci (Arakawa et al. 2011; Fritsche et al. 




While common variants tag the associated genomic region, rare variants coding 
can provide more specific clues about the underlying disease mechanism (Nejentsev et al. 
2009).  For example, the rare variant R1210C in the CFH gene was recently associated 
with a large increase in AMD risk using targeted sequencing of rare CFH risk haplotypes 
(Raychaudhuri et al. 2011). The resulting altered protein has decreased binding to C3b, 
C3d, heparin and endothelial cells (Manuelian et al. 2003; Jozsi et al. 2006; Ferreira et al. 
2009). A reduction in CFH’s ability to inactivate C3, leading to increased cell killing 
activity by the complement pathway, could contribute to AMD – a much more specific 
and testable hypothesis about disease mechanism than provided by common CFH 
variants whose mechanistic consequences are unclear.  
To systematically identify rare, large-effect variants, we carried out targeted 
sequencing of eight AMD risk loci identified in GWAS (Chen et al. 2010) (near CFH, 
ARMS2, C3, C2/CFB, CFI, CETP, LIPC and TIMP3/SYN3) and two candidate regions 
(LPL and ABCA1) (Table 2-2). We re-sequenced these regions in 3,124 individuals 
(2,335 cases and 789 controls) recruited in ophthalmology clinics at the University of 
Michigan and at the University of Pennsylvania and among Age-Related Eye Disease 
Study (AREDS) participants (Age-Related Eye Disease Study Research Group 2000; 
Chen et al. 2010). Genomic targets were enriched using a set of 150-bp probes designed 
by Agilent Technologies, and sequence data was generated on Illumina Genome 
Analyzer and HiSeq instruments. The ten loci comprised 115,596 nucleotides of protein 
coding sequence and totaled 2,757,914 nucleotides overall. We designed probes to 
capture 111,592 nucleotides (96.5% of coding sequence) and 966,607 nucleotides overall 




bases of on-target sequence per individual (an 127.5x average depth counting bases with 
quality >20 in reads with mapping quality >30, after duplicate read removal); 98.49% of 
sites with designed probes were covered at >10x depth. We applied the same variant 
calling tools and quality control filters similar to those used to analyze NHLBI Exome 
Sequencing Project data (Tennessen et al. 2012; Fu et al. 2013) (Table 2-6). We 
identified an average of 1,714 non-reference sites in each sequenced individual. In total, 
this resulted in 31,527 single nucleotide variants of which 18,956 were not in dbSNP 135. 
Discovered sites included 834 synonymous variants, 1,380 nonsynonymous variants and 
43 nonsense variants. Among 13 samples sequenced in duplicate, genotype concordance 
was 99.82% (when depth >10x). Among 908 samples previously examined with GWAS 
arrays (Chen et al. 2010), sequence-based genotypes were 98.99% genotype concordant 
with array-based calls (again, when depth >10x).  
In an initial comparison of AMD cases and controls, no rare coding variants with 
frequency <1% reached experiment wide significance (p < 0.05 / 31,527 = 1.6x10
-6
, 
including all discovered variants, or p < 0.05 / 1,423 = 3.5x10
-5
 considering only protein 
altering variants), although several showed encouraging patterns. For example, rare 
variant R1210C in the CFH gene was observed in 23 of the 2,335 sequenced cases, but in 
none of the 789 sequenced controls (exact test p=0.0025). Common variants in several 
loci exhibited strong evidence of association, including in CFH (peak variant rs9427642 
with case frequency fcase = 12%, control frequency fcontrol = 27%, P-value = 2.52x10
-48
), 
ARMS2 (rs10490924, fcase = 33%, fcontrol = 18%, P-value = 5.48x10
-27
), C3 (rs2230199, 
fcase = 25%, fcontrol = 17%, P-value = 3.94x10
-9
), C2/CFB (rs556679, fcase = 7%, fcontrol = 






A key requirement for establishing significance of rare disease associated variants 
is the availability of sufficient numbers of control samples. To increase power, we sought 
to identify additional controls and focused on samples from the NHLBI Exome 
Sequencing Project (ESP) (Fu et al. 2013), which sequenced 15,336 genes across 6,515 
individuals. Sequence data for our samples and the NHLBI Exome Sequencing Project 
samples were analyzed with the same analysis pipeline, which minimized potential 
differences due to heterogeneity in analysis tools and parameters. To further avoid 
sequencing and variant calling artifacts, we restricted our analysis to sites within regions 
targeted in both sequencing experiments, genotyped and covered with >10 reads in >90% 
of the samples examined in each project, and >5-bp away from insertion/deletion 
polymorphisms catalogued by the 1000 Genomes Project (The 1000 Genomes Project 
Consortium et al. 2012). Since careful matching of genetic ancestry is critical for rare 
variant association studies (Mathieson and McVean 2012; The 1000 Genomes Project 
Consortium et al. 2012), we selected an ancestry-matched subset of our samples and of 
samples from the NHLBI Exome Sequencing Project. We used principal components 
analysis to construct a genetic ancestry map of the world with samples from the Human 
Genome Diversity Project, each genotyped at 632,958 SNPs (Novembre et al. 2008; 
Wang et al. 2014). If GWAS array genotypes were available for our samples and for the 
NHLBI Exome Sequencing Project samples, it would be straightforward to place them 
directly in this genetic ancestry map. Using targeted sequence data, however, the analysis 
is more challenging: targeted regions include too few variants to accurately represent 
global ancestry and off-target regions are covered too poorly, precluding estimation of 




developed a new algorithm (described in Companion Manuscript(Wang et al. 2014)) to 
place each sequenced sample in a pre-defined genetic ancestry map of the world. The 
method can accurately place individuals on this worldwide ancestry map with <0.05X 
average coverage of the genome and is thus ideal for targeted sequence data, such as ours 
and the NHLBI Exome Sequence data, which have average off-target coverage of ~0.23x 
and ~0.90x, respectively (see Figure 2-5, which shows that PCA coordinates inferred 
using 0.10x genome coverage or using GWAS array genotypes are highly similar). We 
focused on samples where PCA coordinates could be estimated confidently (Procrustes 
similarity larger than 0.95; see Appendix) and used a greedy algorithm to match cases 
and controls based on estimated genetic ancestry. As shown in the Appendix, alternative 
matching algorithms do not alter our conclusions. After matching, we focused on a set of 
2,268 AMD cases and 2,268 ancestry-matched controls, matched one-to-one. Since AMD 
phenotype information was not available for most controls, we expect that a small 
proportion may eventually develop disease; however, this should not impact power 
substantially (Wellcome Trust Case Control Consortium 2007). After matching case-
control samples, we excluded 1 variant with Hardy-Weinberg Equilibrium test p-value 
<10
-6
 and focused our analysis on 430 remaining nonsynonymous variants.  
In this expanded analysis (see Table 2-1), common variant signals at all loci 
increased in significance (in comparison to Table 2-4). In addition, two rare coding 
variants exhibited association with p < 0.01. The first was R1210C in the CFH gene 
(observed in one control and 23 cases, OR = 23.11, pexact = 2.9×10
-6
), providing strong 
support for the original report (Raychaudhuri et al. 2011). The second variant was K155Q 
in the C3 gene (18 controls, 48 cases, OR = 2.68, pexact = 2.7×10
-4




a previously described common variant signal nearby, rs2230199 (fcontrol = 20.63%, fcase = 
25.26%, marginal pexact = 1.8×10
-7
, OR = 1.31), the evidence for association with K155Q 
increased slightly (conditional OR = 2.91, pexact = 2.8×10
-5
). Inspection of the raw read 
data shows the variant is well supported and is unlikely to be a sequencing or alignment 
artifact (see Figure 2-6 and Figure 2-7). 
Further strong evidence for association of this variant with macular degeneration 
is provided in independent work by deCODE Genetics, examining 1,143 Icelandic 
macular degeneration cases and 51,435 Icelandic controls (control frequency 0.55%, OR 
= 3.45, p = 1.1x10
-7
; companion manuscript by Drs. Unnur Thorsteindottir and Kari 
Stefansson submitted simultaneously(Helgason et al. 2013)). In 1,606 directly genotyped 
cases of macular degeneration from the Age-Related Eye Disease Study II (The AREDS2 
Research Group et al. 2012) the variant has frequency 1.77%, similar to our sequenced 
AMD cases (frequency 1.10%) and the deCODE AMD cases and is notably higher than 
in our sequenced controls (0.30%), in NHLBI Exome Sequencing Project participants 
with primarily European Ancestry (0.40%) and in deCODE controls (0.55%). 
 
We next investigated the potential functional consequences of the K155Q variant. 
Figure 1 shows that CFH variant R1210C (OR=23.11), C3 variant K155Q (OR=2.91) 
and C3 variant R102G (OR=1.31) all map near the surface where CFH and C3b interact 
and can potentially affect binding of complement factor H to C3b. Factor H inhibits C3b 
and limits immune responses mediated by the alternate component pathway. The analysis 




binding of the first macro-globular domain of C3 to CFH and thus potentially interfere 
with inactivation of the alternative component pathway (Heurich et al. 2011). 
Interestingly, the three variants (R102G and K155Q in C3 and R1210C in CFH) all are 
associated with replacement of a positively charged residue.  
In summary, our work and the companion paper identify K155Q as a rare C3 
variant associated with a ~2.91-fold increased risk of macular degeneration. Together 
with rare CFH variant R1210C and previously described common C3 variant R102G, 
K155Q may reduce binding of CFH to C3b, inhibiting the ability of Factor H to 
inactivate the alternative complement pathway. Our work relied on targeted sequencing 
of GWAS loci, genetic ancestry matching of our sequenced samples to additional 
sequenced controls analyzed with the same variant calling and filtering tools, focused 
analysis of regions deeply sequenced in both our project and previously sequenced 
controls, and avoidance of common calling artifacts near insertion/deletion 
polymorphisms. The use of publicly available samples to augment control sets may be 
useful to many targeted sequencing studies, but the strictness of matching and variant 
filtering required for preventing false-positive findings due to population stratification 
and/or sequence analysis artifacts are areas deserving of further study. As the number of 
sequenced human genome and exomes grows, we expect that the utility of the approach 
will grow – making it possible to match multiple controls to each case and making it 
possible to focus on progressively finer ancestry matches. Our results also emphasize that 
large sample sizes will be required for rare variant studies of complex human traits, and 
illustrate the promise of these studies to highlight disease biology, as illustrated by the 





2.3 Ancestral inference using next generation sequence data 
This section describes a joint work with Chaolong Wang and the texts of this section 
based on (Wang et al. 2014). 
2.3.1 Ancestral inference method 
We develop the LASER (Locating Ancestry using Sequence Reads) method to infer 
ancestry of sequence samples. It uses genotype data of external reference panel, which 
usually includes genome wide markers and includes diverse populations. We use the 
HGDP data of 938 individuals of 53 worldwide populations in this paper. Our method 
can utilize targeted sequencing data or exome sequencing data. For example, we can use 
the AMD case-control targeted sequencing data or the 1000 Genome Project exome 
sequencing data. 
The LASER method consists of four steps (Figure 2-2), including (1) PCA on genotype 
data, (2) simulation of sequence reads, (3) PCA on sequence data, and (4) Procrustes 
analysis. Step 1 is only performed once for the reference panel, and steps 2-4 are repeated 
independently for each study sample until all samples are mapped in the reference PCA 
space. If PCA coordinates of the reference panel are available, we can directly use the 
coordinates and skip the first step. Details of each step are described below. 
PCA on genotype data. We code reference data consisting of autosomal SNP genotypes 
for   individuals across   loci as     matrices  , in which           or missing, 
representing the number of copies of the reference allele at locus   for individual  . To 




               , for           and          . In this equation,    and    
represent the  th column mean and standard deviation of  , and were calculated using 
non-missing entries. If locus   was monomorphic (i.e.,      , we set all entries in 
column   of matrix   to be 0. Missing entries in   were also set to 0 in  . We then 
performed eigen decomposition on the     matrix     . The  th PC is given by 
  
   
 ⃗ , in which    is the  th eigen value of matrix , sorted in decreasing order, and  ⃗  
is the corresponding eigen vector. We recorded coordinates of the top   PCs for   
reference individuals in     matrix  .  The PCA method described here is similar to 
that in Wang et al. (2012) (Wang et al. 2012) except for a slight difference in the 
standardization procedure. 
Simulating sequence data for the reference individuals. To analyze sequence data of 
one study sample together with the genotype data of   reference individuals, we 
simulated sequence data for the reference individuals to match the coverage pattern of the 
study sample. This allowed us to estimate eigen vectors appropriate for analysis of low 
coverage data. An alternative approach is calling genotypes across the whole genome, but 
it is challenging to obtain accurate genotypes at most low-coverage sites. We denote the 
simulated sequence data for   reference individuals as two     matrices,    and   , 
representing the simulated coverage and the counts of reference alleles at   loci. Given 
one study sample  , we simulated sequence data for the reference individuals by fixing 
the simulated coverage as    
      (for           and          ; thus exactly 
matching the coverage at the sample being analyzed), and drawing the count of  reference 
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in which,   was the estimated sequencing error rate per base. We set   to 0.01 across all 
loci unless otherwise noted. If     was missing, we accordingly set    
  to missing.  
PCA on combined sequence data. When analyzing sample h, sequence data for each of 
the   reference individuals is simulated to match     (row   in matrix   which is also the 
coverage profile of sample  ) and thus genetic variation in the reference panel is reflected 
only in matrix   . To perform PCA on the reference individuals together with the study 
sample, we first stacked matrix    and the row vector     (corresponding to row   in 
matrix  ) to produce an         matrix   . When examining off-target regions in a 
targeted sequencing experiment, most loci have zero reads (i.e.,      ) and many 
columns in matrix    are uninformative because all elements equal 0. To reduce 
computational complexity, we excluded these uninformative columns from    and 
obtained a        ̃ matrix  ̃, in which  ̃   . We then performed PCA on matrix  ̃ 
following the procedure described in the section PCA on genotype data. We recorded 
coordinates of the top   PCs for the reference individuals as an     matrix  , and for 
the study sample as a     row vector    . This set of PCs from sequence data can be 
compared with PCs from genotype data as described next. 
Procrustes analysis. To place the study sample into the PCA space generated by 
genotypes of the reference individuals, we applied Procrustes analysis(Schönemann and 




maximizes the similarity between      and   while preserving the relative pairwise 
distances among points within  . The optimal transformation   can be analytically 
expressed by equations 2-4 in Wang et al. (Wang et al. 2010), including translation, 
scaling, rotation, and reflection. The similarity between   and   can be quantified by a 
Procrustes similarity statistic        √   , in which   is the minimum sum of 
squared Euclidean distances between      and   across all possible transformations.   is 
given by equation 6 in Wang et al. (Wang et al. 2010), which has been scaled to range 
from 0 to 1. After identifying   based on   and  , we applied the transformation to     
such that    
         represents coordinates of the study sample in the reference PCA 
space  . The Procrustes similarity statistic        reflects the accuracy of     
 ; lower 
similarity between   and   corresponds to greater uncertainty in   and therefore a less 
reliable     
 . LASER reports the Procrustes similarity statistic        for each sample so 
that users can filter out samples expected to have less accurate ancestry estimation.  
2.3.2 Simulation  
Simulation of Sequence Data for Method Validation 
We first simulated the coverage independently across   loci for    test individuals from a 
Poisson distribution:                 for            and          . For the 
HGDP,        and          , and for the POPRES,        and          . 
Then we draw copies of the reference alleles             using the binomial distributions 
given by Equation 1 with a uniform sequencing error rate       . For both the test sets 




varying   from 0.001 to 0.40. The expected number of loci with    reads is calculated 
as          
    for each simulated dataset (Table 2-5, Table 2-6). 
We also performed additional simulations to explore how our method can help exome 
sequencing studies. We used genotypes for 385 POPRES individuals (the same set of 
samples that were used in previous simulations) as templates to simulate sequence reads 
across 318,682 loci. Instead of simulating the coverage, we used the empirical coverage 
patterns in 385 exomes from the NHLBI Exome Sequencing Project (Fu et al. 2013). 
Among the 318,682 loci, 2,547 loci were targeted and had mean coverage ~88.9X. The 
remaining 316,135 off-target loci had mean coverage ~1.0X. 
Estimating Coordinates based on SNP Genotypes 
To evaluate the performance of LASER, we compared the sequence-based coordinates 
estimated by LASER with coordinates estimated using SNP genotypes. The method to 
place a sample into an existing PCA space of   reference individuals based on SNP 
genotypes is similar to our LASER method, except that we do not need to simulate 
sequence reads for the reference panel. We first combined the genotype data of the study 
sample and   reference individuals, and then perform PCA on the shared set of SNPs for 
these     individuals. Finally, we used the same Procrustes analysis approach as 
described in the LASER method to project the study sample into the reference PCA space. 
We repeated this procedure for all study samples whose SNP genotypes were available. A 
very similar approach was previously applied to study ancient DNA samples. Those 
samples have large amount of missing genotypes but do not have sequence data 




For a set of test samples, we used the squared Pearson correlation    to measure the 
concordance between the sequence-based coordinates and the SNP-based coordinates 
along each PC. We also reported an overall similarity measurement between two sets of 
coordinates using the Procrustes similarity statistic   , which was obtained by applying 
Procrustes analysis to sequence-based coordinates and SNP-based coordinates of the test 
samples. 
Evaluation based on simulation 
For the worldwide sample set, we randomly selected 238 individuals from the HGDP 
(Novembre et al. 2008), and used their array genotypes at 632,958 loci as templates to 
simulate sequence data. We simulated multiple sequence datasets with mean coverage 
ranging from 0.001X to 0.25X. The remaining 700 HGDP samples were used to construct 
the reference PCA space. We examined the first four principal components. These can be 
used to separate major continental groups in the HGDP (Figure 2-3): PC1 and PC2 
separate major continental groups in the Old World (Figure 2-3 A), while PC3 and PC4 
further separate Native American and Oceanian populations, respectively (Figure 2-3 B). 
We applied LASER to each simulated sequence dataset to estimate the ancestry 
coordinates of the test individuals in the reference PCA space. We assessed the accuracy 
by comparing ancestry estimates derived from LASER to PCA coordinates of the test 
individuals based on their original SNP genotypes using the squared Pearson correlation 
   along each PC and the Procrustes similarity   . Our results show consistently high 
accuracy across all simulated datasets (Figure 2-3, Table 2-5). When the simulated 
coverage is 0.001X (corresponding to ~630 loci covered with    reads),    ranges from 




and D in Figure 2-3 show that although the patterns are a bit fuzzy, major continental 
groups are well separated at 0.001X coverage. Accuracy increases with coverage; when 
the coverage is 0.10X, the estimated coordinates are almost identical to coordinates 
estimated using a GWAS SNP panel with           (Figure 2-3, Table 2-5). Thus, our 
method should be able to reconstruct worldwide ancestry with even very modest amounts 
of sequence data. 
Similarly, for estimates of fine-scale ancestry within Europe, we used genotypes at 
318,682 loci and 385 randomly selected POPRES individuals (Novembre et al. 2008) as 
templates to simulate low coverage sequence data (from 0.01X to 0.40X). The remaining 
1,000 POPRES European ancestry samples were used to construct the reference PCA 
space. We focused on the top two PCs of the POPRES reference panel, which mirror the 
geographic map of Europe (Novembre et al. 2008) (Figure 3A). Compared to the 
estimates of worldwide continental ancestry, much higher coverage is required to reveal 
the more subtle differences in population structure within Europe (Figure 2-4, Table 2-6). 
With an average coverage of 0.01X, samples clump in the center of the reference PCA 
space (Figure 2-4 B,           for PC1 and        for PC2,          ). As 
coverage increases to 0.05X (Figure 2-4 C), we become able to observe population 
structure along PC1 (         ), which separates Northern and Southern Europeans, 
but still no structure along PC2 (         ). Clear population structure within Europe 
is revealed when coverage is >0.10X (Figure 2-4 D-F), with    increasing from 0.9126 
(0.10X coverage) to 0.9764 (0.40X coverage) (Table 2-6). Thus, reconstructing ancestry 
within Europe requires substantially more data than reconstructing continental ancestry in 





2.3.3 Infer ancestry of samples in AMD study 
We next applied LASER to 3,159 samples sequenced around 8 macular degeneration 
susceptibility loci and two candidate regions (Zhan et al. 2013). The samples include 
2,362 macular degeneration cases, 789 controls, two samples with unknown phenotype, 
and one European (CEU) and one Yoruba (YRI) nuclear family selected among the 
HapMap Project samples (each nuclear family included mother, father and a child). 
Macular degeneration cases and controls were recruited in Ophthalmology clinics across 
the United States. In these samples, off-target coverage was 0.224X across the 633K loci 
in HGDP, and 0.241X across the 319K loci in POPRES. When using the HGDP as the 
reference panel, the two trios were placed to the correct positions: the CEU trio clustered 
with the HGDP Europeans, and the YRI trio clustered with the HGDP Africans. Diverse 
ancestral background was observed among the 3,153 case-control samples: 3,069 
clustered with Europeans/Middle Eastern ancestry individuals; 73 aligned between 
Africans and Europeans (likely corresponding to African American samples); 5 aligned 
between Europeans and Native Americans; 3 clustered with Central/South Asians; and 3 
clustered with East Asians (Figure 2-7 A-B). We then used the POPRES reference panel 
to dissect the population structure among samples in the cluster with European/Middle 
Eastern ancestry. Our results show that although most of these samples had northern 
European ancestry, many other samples formed a small cluster around southern Europe 
(Figure 2-8 C-D). For 931 of the sequenced AMD cases and controls, GWAS array 
genotype data are also available (Chen et al. 2010). For these samples, results based on 




both the HGDP PCA space (         , Figure 2-9) and the POPRES PCA space 
(         , Figure 2-10). The accuracy increased for samples with higher off-target 
coverage (Table 2-7).  
 
2.4 Conclusion and discussion 
This chapter presents a complete AMD target-sequence study. Our work has augmented 
with publicly available control data, replicated a previously reported rare variant 
association in the CFH gene and identified a new rare variant signal in the C3 gene. In 
both instances, these rare variants are associated with substantially larger odds ratios than 
common variants in the same regions. We hope the finding can improve our 
understanding of the AMD disease etiology. 
The methodology contribution is that we propose a new method that allows the genetic 
ancestry of an individual to be accurately estimated in targeted sequencing experiments. 
This method skips genotype calling and directly analyzes sequence reads to place 
samples into a principal component ancestry map constructed using genotypes for a 
reference set of individuals. After careful validation, we show that the method can 
accurately infer worldwide continental ancestry with whole genome shotgun coverage as 
low as 0.001X. For estimates of fine-scale ancestry within Europe, the method performs 
well with coverage of 0.1X, as illustrated by the analysis of samples from a targeted 







Macular degeneration cases and controls were recruited at Ophthalmology clinics 
at the University of Michigan and the University of Pennsylvania and through the Age 
Related Eye Diseases Study, as previously described. All participants provided informed 
consent.  
 
Sequence Production and Quality Control 
Illumina multiplexed libraries were constructed with 5µg of whole genome 
amplified material or 1µg native genomic DNA according to the manufacturer’s protocol 
(Illumina Inc, San Diego, CA) with the following modifications: 1) DNA was fragmented 
using a Covaris E220 DNA Sonicator (Covaris, Inc. Woburn, MA) to range in size 
between 100 and 400bp.  2) Illumina adapter-ligated library fragments were amplified in 
four 50µL PCR reactions for eighteen cycles.  3) Solid Phase Reversible Immobilization 
(SPRI) bead cleanup was used for enzymatic purification throughout the library process, 
as well as final library size selection targeting 300-500bp fragments.   Ninety percent of 
the samples for this project had four multiplexed libraries pooled together while the 
remaining ten percent had twenty-four multiplexed libraries pooled prior to 
hybridization.  A custom targeted probe set of 150bp probes was designed (Agilent 
Technologies, Santa Clara, CA) and captured 0.97 Mb of sequence from 10 loci 
(spanning 2.76Mb and including 57 genes).  The concentration of each captured library 




(Kapa Biosystems, Inc, Woburn, MA) to produce cluster counts appropriate for the 
Illumina GAIIx and HiSeq 2000 platforms.  Pools of four samples were loaded on the 
GAIIx and pools of twenty four samples were loaded on the HiSeq.   With the throughput 
of both instruments, one lane of 2 x 101bp paired end sequence data generated 
approximately 1.7 GB per sample.  This data quantity covered 80% of the targeted space 
at a depth of 20x or higher. Reads from each sample were aligned to the NCBI37/hg19 
reference sequence using BWA. For approximately forty percent of the sample set where 
pre-existing genotype information was available, sample identity was confirmed by 
comparing sequence data (SAMtools consensus calls) with pre-existing genotype array 
data and only samples with >90% concordance were carried forward to analysis. 
 
Quality control and variant calling 
Sequence data was generated for 3159 samples. Quality control steps for all BAM 
files included: removal of duplicated reads using MarkDuplicates in Picard 1.42; 
recalibration of base qualities using GATK(McKenna et al. 2010) 1.0.5974; diagnostic 
graphs and evaluation of sequencing quality using QPLOT (Li et al. 2013); check for 
contamination using verifyBamId (Jun et al. 2012). After removing samples with high 
contamination, unexpected relatedness or with high discordance rate, we analyzed 3124 
samples retaining 2,335 cases and 789 controls for an initial round of analysis. 
We calculated the sequencing depth using high quality reads (BWA mapping 
quality >30) and bases (recalibrated base quality >20). Across the 966,607 base pair 




127.5x average coverage. Within targeted regions, 98.49% of the protein coding exons 
had coverage >10x.  
We performed variant calling step using UMAKE, which was also used for 
variant calling in the NHLBI Exome Sequencing Project (Fu et al. 2013). Genotype 
calling and polymorphism discovery was attempted across an “extended target region” 
(original target +/- 50 base pairs). To remove low quality variants, we excluded: 1) sites 
with average depth <0.5 or >500; 2) sites with evidence of strand bias or cycle bias; 3) 
sites within 5 base pairs of a 1000 Genomes Project indel; 4) sites with excess 
heterozygosity. These filters excluded 15,219 low quality variants. The transition-
transversion ratio (Ts/Tv) for the remaining 31,527 site was 2.10. In addition, we 
examined concordance rates between sequenced-based genotypes for 13 duplicated 
samples, which was 99.82% when depth >10x.  The concordance rate between array-
based genotypes and sequence-based genotypes for 908 samples overlapping with our 
GWAS experiment was 98.99% when depth >10x.  
In this sequencing experience, 59.8% of discovered variants are novel (not 
previously reported in dbSNP 135 or 1000 Genomes Project). The variant call set 
included 834 synonymous variants, 1380 nonsynonymous variants and 43 nonsense 
variants overall. On average, each sample carried 40 synonymous variants, 34 






Using 2,335 cases and 789 controls, we first performed single variant tests on 
41,202 variants using Fisher’s exact test. This analysis confirmed strong association for 
common variants near CFH, C2, ARMS2 and C3 genes (as expected). An initial 
examination of rare variants suggested some effects were shadows of common variants 
with larger effects, so we focused on the rare variant with MAF less than 1% where 
association remained significant after accounting for nearby common variants using 
sequential logistic regression (Chen et al. 2010). The marginal association for each 
variant was evaluated using Fisher’s exact test and conditional signals were evaluated by 
exact logistic regression (Cox and Shell 1970; Hirji et al. 1987). This analysis identified 
three coding variants with conditional exact P-value less than 0.01 (all also had marginal 






Augmenting population controls 
To increase power, we identify appropriate ancestry matched controls for our 
samples among samples sequenced in the ESP project. Major challenges in this analysis 
are (a) comparing our data set and ESP data set, which were sequenced using different 
protocols, and (b) ensuring that the genetic background of cases and controls was 
appropriately matched. 
To avoid the potential effects of population stratification, we matched case and 
control samples based on genetic ancestry. First, we use genome-wide reads to infer 
sample ancestries on a worldwide population map [summarized in four principal 
components of ancestry]. The process for placing samples on this worldwide ancestry 
map is described in detail in a companion manuscript (Wang et al. 2014). Briefly, we first 
generate a genetic ancestry PCA space using genotyped reference samples (such as those 
from the Human Genome Diversity Panel). Then, we generate a series of sample specific 
genetic ancestry PCA that are calibrated to the exact sequencing depth and coverage 
pattern of each sample and include the reference samples together with a single 
sequenced sample. Finally, we transform these sample-specific PCA coordinates to the 
original map using Procrustes analysis. This procedure generates a metric (the Procrustes 
similarity) that summarizes similarity of reference sample placements using array 
genotypes to placements using sequence data and we only considered samples where this 
metric was >0.95 as candidates for matching. Second, we used a procedure inspired on 
propensity score matching to pair cases and controls (Rosenbaum and Rubin 1983).  
Briefly, this procedure uses logistic regression to predict the probability that an individual 




as the outcome.  This estimated probability of being a case for each sample is a 
propensity score and can be used to match cases and controls. For matching, we used a 
greedy algorithm to match cases and controls; allowing matches when the respective 
propensity scores differed by <.0001. An alternative matching algorithm that matched 
cases and controls mapping close together in principal component space according to the 
Euclidean distance between them gave similar results (association at K155Q had 
OR=2.68, exact p-value 4.5x10
-5
 using Fisher’s exact test).  
To avoid variant calling artifacts, we applied very stringent filters to both the 
AMD study and ESP study call sets. For both studies, we examined only sites with call 
rates >90%, Phred-scaled variant quality scores >30, passing all study specific quality 
control filters, with depth >10x for >90% of the samples in the AMD or ESP callsets, 
and >5-bp from a 1000 Genomes Project indel. In the combined variant call set, we 
examined 1,148 variants including 280 synonymous variants, 416 nonsynonymous 
variants and 10 nonsense variants.  
 
Analyses using the combined AMD and ESP data set 
After matching, 2,268 cases were matched to 2,268 controls and 1,148 variants 
[of which 708 were coding variants] were available for analysis. Similar to our initial 
analysis, we first applied Fisher’s exact test for association to all variants. With this larger 
control set, common variants in LPL and CETP genes reached significance in addition to 




frequency <1% for which signal remained significant after adjusting for the K155Q 
signal. This analysis highlighted R1210C in CFH and K155Q in C3 (Figure 1).  
 
Additional Variant Quality Checks for K155Q 
As in Figure 2-6, we examined read depth at the K155Q variant, in comparison to 
other sites and across individuals. Average depth of coverage at K155Q in the ESP and 
AMD studies was 90.5x and 63.7x respectively (Figure 2-6 A, B). The average depth at 
samples with heterozygous genotypes at K155Q was 87.9x and 64.1x respectively 
(Figure 2-6 C, D).  
To avoid possible alignment artifacts, we inspected raw read alignments in the 
region for a subset of samples using hapviz (Garrison). As shown in Figure 2-7, there are 
no patterns indicative of alignment artifacts (excess of reads with mismatches or hard to 
align insertion deletion polymorphisms) and reads representing the reference and 








2.6 Figures and tables 
Figure 2-1 R102G and K155Q variants 
 
C3 variants R102G and K155Q and CFH variant R1210C are in the interaction domains 
the first alpha-macro-globular domain of C3b and CFH, respectively. The fragment of the 
crystal structure of the four Sushi domains (purple in figure, one not shown for clarity) of 
CFH in a complex with complement fragment C3b (PDB file: 2wii) was used to explore 
the effect of disease associated nonsynonymous changes. The CFH residues 987-1230 




structural template (shown in pink, with cysteine residue side chains in yellow). The C-
terminal Sushi domains were docked to the binding site in C3b. The first two alpha-
macro-globulin domains of C3b, MG-1 and MG-2, are shown in green and cyan, 











Figure 2-3 Estimation of worldwide continental ancestry 
238 individuals were randomly selected from the HGDP as the testing set (colored 
symbols), and the remaining 700 HGDP individuals were used as the reference panel 
(gray symbols). (A-B) Results based on SNP genotypes. (C-D) Results based on 
simulated sequence data at 0.001X coverage. The Procrustes similarity to the SNP-based 
coordinates is          . (E-F) Results based on simulated sequence data at 0.01X 
coverage (         ). (G-H) Results based on simulated sequence data at 0.10X 







Figure 2-4 Estimation of ancestry within Europe 
385 individuals were randomly selected from the POPRES as the testing set (colored 
symbols), and the remaining 1,000 POPRES individuals were used as the reference panel 
(gray symbols). (A) Results based on SNP genotypes. (B) Results based on simulated 
sequence data at 0.01X coverage. The Procrustes similarity to the SNP-based coordinates 
is          . (C) Results based on simulated sequence data at 0.05X coverage 
(         ). (D) Results based on simulated sequence data at 0.10X coverage (   
      ). (E) Results based on simulated sequence data at 0.20X coverage (         ). 
(F) Results based on simulated sequence data at 0.40X coverage (         ). 
Population labels follow the color scheme of Novembre et al. (2008) (Novembre et al. 
2008). Abbreviations are as follows: AL, Albania; AT, Austria; BA, Bosnia-Herzegovina; 
BE, Belgium; BG, Bulgaria; CH-F, Swiss-French; CH-G, Swiss-German; CH-I, Swiss-
Italian; CY, Cyprus; CZ, Czech Republic; DE, Germany; DK, Denmark; ES, Spain; FI, 
Finland; FR, France; GB, United Kingdom; GR, Greece; HR, Croatia; HU, Hungary; IE, 
Ireland; IT, Italy; KS, Kosovo; LV, Latvia; MK, Macedonia; NL, Netherlands; NO, 
Norway; PL, Poland; PT, Portugal; RO, Romania; RU, Russia; Sct, Scotland; SE, 






Table 2-1 Summary association ressults for 2,268 sequenced AMD cases and 2,268 sequenced controls 












Cases Controls OR P-value 
Conditional 
P-value 
Common variant hits 
rs200244837 1  196,884,290  CFH Intron:CFHR4 T/A 0.020 0.109 0.17 6.7 x10-73  
rs6467 6  32,006,858  C2 Intron:CYP21A2 C/A 0.760 0.637 1.81 1.2 x10-37  
rs255 8  19,811,901  LPL Intron:LPL T/C 0.151 0.088 1.83 3.6 x10-20  
rs45519541 10  124,183,691  ARMS2 Intron:PLEKHA1 T/C 0.145 0.037 4.41 1.5 x10-75  
rs11076176 16  57,007,446  CETP Intron:CETP T/G 0.145 0.177 0.79 4.4 x10-5  
rs2230199 19  6,718,387  C3 R102G G/C 0.253 0.206 1.30 1.8x10-7  
           
Rare variant hits MAF < 1% Conditional P <.01 Sort by P 
rs121913059 1  196,716,375  CFH R1210C C/T 0.005 0.000 23.11 2.9x10-6 6.0x10-4 
rs147859257 19  6,718,146  C3 K155Q T/G 0.011 0.004 2.68 2.7x10-4 2.8 x10-5 
 
 
All p-values were calculated using exact logistic regression. For rare variants, we re-evaluated statistical significance after adjusting 




2.7 Supplementary figures and tables 
Figure 2-5 Ancestry based matching using the HGDP reference Panel 
We label red color as cases and blue color as controls. We showed AMD samples’ ancestry using their genotype data in panel A (PC1 and PC2) and 
in panel E (PC3 and PC4). Comparatively, we showed the same set of samples’ ancestries using off-target sequencing reads in panel B (PC1 and PC2) 
and in panel E (PC3 and PC4). These four panels illustrated the similar ancestries can be inferred from either genotype data or target sequencing data. 
After we matched 2,268 cases and 2,268 controls from AMD study and ESP study, we showed their ancestries in Panel C (PC1 and PC2) and Panel 
G (PC3 and PC4). Cases (red) and controls (blue) are well matched in each graph. Further, we displayed the K155Q variant carriers’ ancestries in 










Figure 2-6 Depth distribution and sequencing alignment diagnostics. 
Panel A: Density plot comparing average sequencing depth at K155Q in our targeted sequence data (red line) to that in the 1,148 sites examined in 
the comparison to ESP (histogram). The average sequencing depth at K155Q was 63.73. 
Panel B: Density plot comparing total sequencing depth at K155Q in ESP (red line) to that in the additional 1,148 ESP sites examined in the 
comparison to ESP (histogram). The average sequencing depth at K155Q was 90.53. 
Panel C: Density plot examining depth at K155Q in heterozygote carriers in our targeted sequencing sample. The red line marks average depth 
(64.11) at K155Q for carriers, the histogram summarizes depth distribution across all genotyped sites. 
Panel D: Density plot examining depth at K155Q in heterozygote carriers in the ESP sample. The red line marks average depth (87.93) at K155Q for 









Figure 2-7 Sequencing reads aligned to K155Q variant. 
We examined the reads covers the K155Q variants and show that the alignment pattern is clear and that 37 reads overlap this variant. Below the 
reference genome, all the reads overlapping the site in a predicted K155Q heterozygote are listed. For ease of visualization, we use a ‘-’ (dash) to 
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Figure 2-8 Estimation of ancestry for 3,159 samples in the AMD targeted sequencing dataset. 
 (A-B) Results based on the HGDP reference panel, whose colors and symbols follow Figure 2-3. AMD samples are displayed in 
black, with different symbols representing possible ancestries based on their estimated PC coordinates. Two HapMap trios are labeled 
in gray. (C-D) Results based on the POPRES reference panel. Panel C displays PC1 and PC2 of the POPRES; panel D displays 3,072 
AMD samples on top of the POPRES. These samples are possibly Europeans or Middle Eastern as indicated in panels A and B. 
Population labels for the POPRES samples are as follows: AL, Albania; AT, Austria; BA, Bosnia-Herzegovina; BE, Belgium; BG, 
Bulgaria; CH-F, Swiss-French; CH-G, Swiss-German; CH-I, Swiss-Italian; CY, Cyprus; CZ, Czech Republic; DE, Germany; DK, 
Denmark; ES, Spain; FI, Finland; FR, France; GB, United Kingdom; GR, Greece; HR, Croatia; HU, Hungary; IE, Ireland; IT, Italy; 
KS, Kosovo; LV, Latvia; MK, Macedonia; NL, Netherlands; NO, Norway; PL, Poland; PT, Portugal; RO, Romania; RU, Russia; Sct, 








Figure 2-9 Sequence-based coordinates and SNP-based coordinates for 931 AMD samples when using the HGDP reference panel. 
Colors and symbols for HGDP and AMD samples follow Figure 2-3, respectively. (A-B) Results based on 45,700 SNPs that are 
shared by the HGDP, the POPRES, and the AMD SNP datasets. (C-D) Results based on off-target sequence data. The Procrustes 
similarity between results in panels A-B and in panels C-D is          .  
        , 0.8881, 0.6031, and 0.1828 for PC1, PC2, 








Figure 2-10 Sequence-based coordinates and SNP-based coordinates for AMD samples when using the POPRES reference panel. 
We only included 928 AMD samples whose genotype data are available and who might be Europeans or Middle Eastern according to 
results in Figure 2-9. (A) Results based on 45,700 SNPs that are shared by the HGDP, the POPRES, and the AMD SNP datasets. (B) 
Results based on off-target sequence data. The Procrustes similarity between results in panel A and in panel B is          . 








Figure 2-11 Manhattan plot of K155Q association signal for 2,268 sequenced AMD cases and 2,268 sequenced controls. 
This plot is produced by LocusZoom (Pruim et al. 2010). The top signal is R102G variant and the second top signal is K155Q variant. 
The shapes of the legends represents annotations (triangle: nonsynonymous variant; rectangle: synonymous/UTR variant; circle: 
nothing; filled shapes: variants within LocusZoom database; hollow shapes: variants not in LocusZoom database; complete list can be 
found from LocusZoom website: http://statgen.sph.umich.edu/locuszoom/). 
The data is selected from AMD dataset and ESP dataset using one-to-one propensity-score based matching. Then the association 
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Table 2-2 Target information 
Interval Target Information   
Chr 
Start 
Position End Position Length 
Protein 
Coding 








1  196,341,101   196,994,612  653,511  11,359   1,520   226,684  34.69  11,007  96.90 CFH 7 
4  110,547,457   110,733,347  185,890  4,116   891   132,950  71.52  4,087  99.30 CFI 4 
6  31,720,915   32,087,186  366,271  66,023   1,393   207,700  56.71  63,090  95.56 C2/CFB 29 
8  19,786,532   19,938,633  152,101  1,428   737   109,963  72.30  1,418  99.30 LPL 1 
9  107,533,234   107,700,286  167,052  10,408   860   128,141  76.71  10,341  99.36 ABCA1 3 
10  124,113,939   124,412,943  299,004  10,432   388   57,812  19.33  10,146  97.26 ARMS2 5 
15  58,555,986   58,870,773  314,787  1,500   197   29,453  9.36  1,488  99.20 LIPC 1 
16  56,980,401   57,026,900  46,499  1,482   61   9,089  19.55  1,451  97.91 CETP 2 
19  6,669,795   6,734,343  64,548  6,469   122   18,178  28.16  6,204  95.90 C3 3 
22  32,904,490   33,412,741  508,251  2,379   313   46,637  9.18  2,360  99.20 SYN3/TIMP3 2 






Table 2-3 Summary of analyzed variants 
Variants were called using UMAKE with standard filters (See supplementary material for details). Comparisons to ESP were 
restricted to regions targeted in both ESP and our experiment, where depth of coverage >10X for 90% of samples, and >5-bp away 
from an insertion-deletion polymorphism (as noted in text).  
# Fraction of variant sites covered. We showed average values and quartile ranges are shown within parentheses.  






  Initial Call Set Protein Coding Regions Sites Compared To ESP 
 
Target Summary 
   
 Targeted nucleotides 2,757,914 115,596 - 
 Examined nucleotides 966,607 111,592 97,196 
 Mean coverage 106.8 128.6 133.0 
 Fraction >10x
#
 .95 (.92-.99) .98 (.98-1.00) .98 (.98-1.00) 
 
Overall 
   
 SNP    
 No. sites 31,527 2,368 1,148 
 No. in 1000 Genomes Phase I 11,721 750 707 
 No. in dbSNP 135 12,571 1,017 797 
 Fraction Novel
*
 59.82% 55.03% 25.78% 
 No. synonymous 834 834 280 
 No. nonsynonymous 1,380 1,380 416 
 No. nonsense 43 43 10 
 Ts/Tv ratio 2.09 2.88 2.73 
 
Variation Per Sample 
   
 SNP    
 No. sites  1,714 78 89 
 No. in 1000 Genomes Phase I 1,650 75 88 
 No. in dbSNP 135 1,691 76 87 
 Fraction Novel
*
 1% 0% 0% 
 No. synonymous 40 40 24 
 No. nonsynonymous 34 34 19 





Table 2-4 Initial statistical association analysis of AMD 2,335 cases and 789 controls. 
All p-values were calculated using exact logistic regression. For rare variants, we evaluated statistical significance after adjusting for 
the top common variant at the locus to avoid shadow signals driven by linkage disequilibrium.  
 






SNP Chromosome Position(bp) Nearest Gene Consequence Alleles (ref/alt) Cases Controls OR P-value 
Conditional 
P-value 
Common variant hits           
rs1061170 1  196,659,237  CFH H402Y C/T 0.481 0.662 0.47 4.48 x10-36  
rs641153 6  31,914,180  C2 R32Q G/A 0.060 0.105 0.55 1.26 x10-8  
rs10490924 10  124,214,448  ARMS2 A69S G/T 0.326 0.184 2.15 1.85 x10-28  
rs2230199 19  6,718,387  C3 R102G G/C 0.247 0.175 1.55 2.31 x10-9 
 
Rare variant hits with MAF < 1% and P <.01 (after conditioning on nearby common variants).  
rs121913059 1  196,716,375  CFH R1210C C/T 0.005 0.000 ∞ 2.57 x10-3 2.00 x10-4 
rs143667999 6  31,922,453  RDBP D208E G/C 0.001 0.005 0.21 5.99 x10-3 6.70 x10-3 






Table 2-5 Results on simulated worldwide samples with different sequencing coverage. 
Sequence data were simulated for 238 individuals randomly selected from the HGDP dataset and the remaining 700 individuals in the HGDP dataset were used 
as the reference panel. For each simulated dataset, we compared the estimated ancestry coordinates of the 238 testing individuals to their SNP-based coordinates 









   reads 















   
0.25 140,010 0.9996 0.9996 0.9992 0.9988 0.9997 
0.20 114,736 0.9996 0.9996 0.9992 0.9986 0.9996 
0.15 88,166 0.9994 0.9996 0.9988 0.9978 0.9995 
0.10 60,234 0.9992 0.9992 0.9982 0.9974 0.9993 
0.05 30,870 0.9988 0.9986 0.9964 0.9946 0.9989 
0.01 6,298 0.9948 0.9932 0.9819 0.9716 0.9949 
0.008 5,043 0.9940 0.9920 0.9783 0.9663 0.9940 
0.006 3,786 0.9896 0.9882 0.9671 0.9586 0.9911 




0.002 1,265 0.9756 0.9706 0.8964 0.8356 0.9729 





Table 2-6 Results on simulated European samples with different sequencing coverage. 
Sequence data were simulated for 385 individuals randomly selected from the POPRES dataset and the remaining 1000 individuals in the POPRES dataset were 
used as the reference panel. For each simulated dataset, we compared the estimated ancestry coordinates of the 385 testing individuals to their SNP-based 









   reads 









   
0.40 105,063 0.9855 0.9078 0.9764 
0.35 94,111 0.9866 0.8945 0.9737 
0.30 82,597 0.9813 0.8725 0.9671 
0.25 70,492 0.9797 0.8540 0.9636 
0.20 57,767 0.9738 0.7973 0.9495 
0.15 44,390 0.9653 0.7763 0.9428 
0.10 30,327 0.9510 0.6647 0.9126 
0.05 15,542 0.8851 0.2516 0.7720 





Table 2-7 Comparison between sequence-based and SNP-based coordinates for a subset of the AMD samples. 
This includes 928 samples analyzed with the POPRES reference panel. 
 














   reads 









   
            232 0.16 34,114 0.9299 0.5460 0.8770 
            232 0.22 45,603 0.9588 0.6655 0.9285 
            232 0.27 54,837 0.9616 0.6821 0.9254 







Chapter 3 More efficient ancestry inference using low-coverage 
sequencing data 
3.1 Introduction 
Genetic studies using next generation sequence (NGS) technology are increasingly 
popular (Mardis 2011). In medical genetics studies, sequencing technology enables the 
discovery of disease associated variants of very low-frequency and can broaden 
understanding of disease etiology.  
To explore rare disease associated variants, genetic association studies need to sequence 
large numbers of samples (Li and Leal 2009). Cost constraints mean there is usually a 
trade-off between the number of samples to be sequenced, sequencing depth and the 
proportion of the genome examined in each sample (Cirulli and Goldstein 2010). For 
example, deep whole-genome sequencing studies provide the most complete information 
per individual but remain an expensive approach (Wetterstrand 2014) and thus typically 
limit the number of samples that can be examined. A popular alternative, targeted 
sequencing studies focus sequencing effort on a pre-designated fraction of the genome. 
These studies can deploy sequencing across 1,000s or 10,000s of samples (O’Roak et al. 
2012). Successful examples of targeted sequencing studies include the association of a 
rare complement factor H variant with  age-related macular degeneration (AMD) 
(Raychaudhuri et al. 2011; Zhan et al. 2013) and of several rare IFIH1 (interferon 




A key question in these studies is the potential to recruit controls from other sequencing 
studies (increasing power and sample size), while controlling genetic and experimental 
heterogeneity as well as avoiding potential population stratification. The consequences of 
population stratification problem have been widely discussed in the context of genome 
wide association studies  (Pritchard and Rosenberg 1999; Cardon and Palmer 2003; 
Freedman et al. 2004; Campbell et al. 2005; Price et al. 2006; Price et al. 2010).  The 
prevailing strategies for controlling stratification in GWAS include assigning samples to 
subpopulation clusters using a model based analysis (Pritchard et al. 2000a; Alexander et 
al. 2009), PCA analysis (Price et al. 2006; Purcell et al. 2007) and analysis using linear 
mixed models (Yu et al. 2006; Kang et al. 2008; Kang et al. 2010). These strategies might 
not work well in sequence based studies of rare variants (Mathieson and McVean 2012). 
Wang et al (2014) suggest an alternative strategy. Their approach, implemented in the 
software LASER, requires an external reference panel that is used to generate an ancestry 
map and coordinate space. LASER then uses sequence data to reconstruct ancestry 
coordinates for each sample and further uses these coordinates to guide one-to-one 
matching of prospective cases and controls. The strategy appears to work well.  
A limitation of the LASER method is that it is computationally demanding and may 
require multiple stochastic analyses of each sample to estimate the most accurate ancestry 
coordinates. Here, we introduce a new model-based approach for ancestral inference 
from sequence data. Extending previous work  (Yang et al. 2012), our likelihood-based 
model of ancestral origin can accommodate low pass or deep sequencing data and model 
sequencing errors. Our method is based on maximum likelihood and we show it is able to 




and analysis of real sequence data, our method shows superior computational efficiency 
and accuracy compared to standard PCA analyses and our previous LASER method.  
3.2 Material and methods 
3.2.1 Workflow 
Our ancestry inference model utilizes a three-step workflow (Figure 3-1 Workflow). In 
the first step, using genotype data on the external reference panel, we calculate reference 
coordinates. In the second step, we estimate SNP allele frequency gradients using pre-
calculated coordinates of reference samples. In the third step, we use the allele frequency 
gradients and sequence data for each study sample to identify the most likely coordinates 
for each sample. We define these as the coordinates that result in a set of allele 
frequencies that maximizes the likelihood of observed sequence data for the sample. The 
inferred ancestry of each sample can be visualized in the coordinate space constructed 
using the reference samples.  
Calculation of reference coordinates  
We calculate reference coordinates from an external reference panel. This panel should 
genome wide genotypes for diverse populations. We apply Principal Component 
Analysis (PCA) on the reference genotypes to obtain coordinates for each reference 
sample (Price et al. 2006).  These coordinates form a reference coordinate space where 
study samples will be in placed in later steps. The calculation of reference coordinates 




Given    reference samples genotyped at  markers, we store genotypes of all reference 
samples in      matrix    where element      denotes the number of reference alleles 
observed at marker j in sample i. We store the estimated PCA for this matrix, which 
represent the ancestral origins for each sample, in matrix  . 
Estimation of SNP gradients 
SNP allele frequency gradients (Figure 3-2) were suggested by Yang et al (Yang et al. 
2012). The gradients represent allele frequencies as a function of ancestral locations and 
allow us to estimate allele frequencies for any population given its ancestral coordinates. 
Specifically, the predicted allele frequency of the  th marker as a function of ancestral 
location     is: 
       
 
   (   
       )   
 
In this equation,    is a vector that describes changes in allele frequency as a function of 
ancestry   , and    is a number that describes allele frequency of the  
th
 variant at the 
origin of the current coordinate space. For simplicity, we let   represent all gradients 
           and   represent all intercepts           .  
To estimate SNP gradients, we follow the work by Yang et al. (Yang et al. 2012), and 
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The above likelihood has been shown to be convex, and therefore SNP gradients   and   
can be inferred through an efficient estimation procedure. The implementation is 
provided in the spa program (Yang et al. 2012).  
These estimated SNP gradients will be in later analysis steps. Like reference ancestry 
coordinates, these only need to be calculated once. They can be re-used in the likelihood 
models for each sample as described in the next step.  
The likelihood model for sequence data 
We extend the model for low-coverage sequencing data where genotypes are not directly 
observed. Instead of observing accurate genotype calls ( ), in sequencing data we 
observe sequence reads. We denote     as the observed sequence data, and     
          where     and     represent the number of reference bases and the number of 
non-reference bases at the  th marker of the  th individual.  
The joint likelihood of all samples on all markers can be written as: 
            ∑        
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(Equation 1) 
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The other term,  (       ), is called the genotype likelihood (Li et al. 2008; Li et al. 
2010) and represents the probability of observed sequence bases as a function of the true 
genotype. The probability can be approximated as: 
 (    (       )|                    
         
 (    (       )|                  
                      
 (    (       )|                
             
In the above formulae,   represents the estimated per-nucleotide base sequencing error. 
Using current technologies, this error rate is usually between 0.1% and 1% (Bentley et al. 
2008; Mardis 2011). Unless noted, we assume this error rate to be 1%. Our simulations 
show that ancestral inference results are not very sensitive to misspecification of this 
parameter. 
Calculation of maximum likelihood estimator (MLE) 
To find the most likely set of ancestral coordinates X for study samples, we maximize L 
with respect to ancestry coordinates for each sample xi (note that our definition of L treats 
each individual independently). We use the simplex method (Figure 3-3) for its simplicity 
(Nelder and Mead 1965). Since the likelihood surface may have more than one mode, we 




3.2.2 HGDP genotype data set 
The Human Genome Diversity Project (Novembre et al. 2008) contains 938 individuals 
from worldwide populations and has genome wide genotypes. Following previously 
described quality control steps (Wang et al. 2014), we analyze 632,907 autosomal SNPs 
with allele frequency >0.  
3.2.3 Simulation of sequence reads using the HGDP data 
We simulate sequence reads for HGDP individuals. The simulation has two steps: first, 
we simulate the sequence depth    for sample   at  th marker from a Poisson distribution 
with mean  . Second, given the sequence depth     and true genotypes    , we simulate 
   , which is the count of reference bases, from binomial distribution as follows: 
            {
        (     )                 
        (       )                 
        (       )                 
 
The simulation parameters evaluated here include sequencing error rates from 0.1% to 10% 
(0.1%, 0.2%, 0.5%, 1%, 2%, 5% and 10%); 15 sequencing depths from 0.001X to 50X 
(0.001X, 0.002X, 0.005X, 0.01X, 0.02X, 0.05X, 0.1X, 0.2X, 0.5X, 1X, 2X, 5X, 10X, 
20X and 50X). These combinations cover various types of typical sequence experiments 
such as targeted sequencing and whole genome sequencing.  
3.2.4 AMD targeted-sequencing data set 
The AMD target-sequence data set (Zhan et al.) consists of 3,159 samples sequenced 
around 8 susceptibility AMD loci and two candidate regions. The samples include 2,362 




YRI trio. The on-target regions span 0.97 Mbp with >85X depth. Coverage of the 
632,907 loci genotyped on HGDP samples averages 0.2X.  
To compare the accuracy of our likelihood method with existing methods, we select 920 
samples among all target-sequenced samples, as they have been previously enrolled in 
GWAS studies (Chen et al. 2010). We use the PCA based ancestry coordinates estimated 
using GWAS genotypes as a gold standard (The coordinates of AMD samples are 
transform to the HGDP reference coordinate space using Procrustes analysis, see Wang et 
al. 2012 for details). Then we apply the LASER method (Wang et al. 2014) and our 
proposed likelihood based method to infer ancestries of each sample and compare the 
three sets of coordinates. 
3.2.5 Evaluation criteria 
To evaluate accuracy, we compared ancestry coordinates estimated using sequence data 
to those estimated using GWAS genotypes. We chose the mean Pearson correlation 
coefficient    between coordinates calculated by applying PCA analysis to GWAS 
genotypes and coordinates calculated using our likelihood-based method as accuracy 
measure of similarity between the two approaches. Suppose the GWAS based PCA 
coordinates for the  th sample are                and the coordinates estimated by our 
likelihood-based method using sequence data are               . We define   
  as the 
Pearson correlation coefficient between      and     , and   
  as the Pearson correlation 
coefficient between      and     ,. Then we define the average squared correlation as 
   
  
    
 
 
. Higher    thus indicates higher similarity between sequence-based and 





3.3.1 Evaluation using simulated sequence data 
First, we evaluate the relationship between sequencing depth and the accuracy of 
estimated coordinates (Table 3-1) using simulated sequence data from HGDP data set. 
With genome wide depth of 0.001X, the likelihood model already works well (e.g. 
          when per base sequencing error = 0.001). As the sequence depth increases 
from 0.001X to 0.2X, the accuracy of the ancestral inference model keeps increasing (to 
          at 0.1X when error = 0.001). When the sequence depth increases further, 
this accuracy increases slightly (e.g.           at 0.2X when error = 0.001).  This 
trend shows that the accuracy of our method is stable at a wide range of sequence depths. 
When the sequence depths are low or moderate, our method performs especially well.  
Second, we evaluated the impact of base sequencing errors on our model (Table 3-1). We 
have simulated data with varying sequencing error, ranging from a high error rate (0.1) to 
a low error rate (0.001). During analysis, we fixed the estimated error rate at 0.01, 
regardless of the true simulated error rate. These settings cover the range of sequence 
error rates that might occur in real data. When the simulated sequencing error rate was 
highest (0.1), our likelihood based method retains high accuracy (e.g.           under 
all simulated sequence depths). When the sequence error rate is low (0.001), the accuracy 
improves.  In general, our likelihood method is not sensitive to the true sequence error. 
Third, we visually compared the ancestral inference results under a variety of simulated 
settings (Figure 3-4). We reviewed 9 ancestry maps for 938 HGDP samples, each 




errors (0.001, 0.01 or 0.1). In all cases, continental population groupings can be 
distinguished. This indicates our method can separate worldwide populations using 
sequence data of different quality profiles. Still, we note that the higher depths and lower 
sequence error rates are preferred, as ancestry maps under these settings have more 
compact population clusters. 
Finally, we show the sequence base error parameter specified in the likelihood model can 
produce robust ancestral inference results (Table 3-1, Table 3-2).We compare the two 
error rates, 0.01 and 0.001. The accuracy (  ) is similar under these different error rates.  
For example, the maximum difference of accuracy is 0.0055 when sequence depth is 
0.1X and error rate is 0.1. In other settings, the difference in terms of    is smaller.  
3.3.2 Evaluation of AMD target-sequence data 
In this evaluation, we use 920 AMD samples to evaluate our likelihood based method 
compared to the PCA method (gold standard) and the LASER method (Wang et al. 2014). 
Our method and the LASER method are both designed to support low-coverage sequence 
data without requiring explicit genotyping of genetic markers. In Figure 3-5, we compare 
the three methods on the first two principal components. When we compared coordinates 
to those estimated directly from GWAS genotypes, our method has slightly higher 
accuracy (         ) than LASER (         ). The two methods provide very 
similar ancestry coordinates (   = 0.9796). In visual comparison, all three methods can 
identify the same set of samples whose ancestral coordinates are clustered to the top 
(which is the cluster of the European HGDP samples). This information is necessary to 




studies (Zhan et al. 2013). In addition to quantitative measurement, we notice the inferred 
origins of some outlier samples (in the bottom right of Figure 3-5) are between the cluster 
of European samples and African samples, which indicates these sequence samples are 
likely to have admixture ancestral background. In all, this likelihood based method shows 
higher concordance compared to existing methods. 
3.3.3 Computational cost 
In addition to the accuracy, our method has excellent computational advantages. When 
analyzing sequence data, the likelihood based method implemented in C++ takes 3 
seconds to estimate coordinates for each sample and consumes 0.5 GB in memory. In 
comparison, the LASER C++ implementation requires 126 seconds and 4.1 GB in 
memory per sample. In addition to sequence data, our program can infer ancestries using 
genotype data. In our evaluation, the program can estimate the first two principal 
components of ancestry using 3 seconds per sample and 0.09 GB in memory. A similar 
analysis using SNPRelate (Zheng et al. 2012), which heavily optimizes matrix algebra 
procedures, takes about 27 seconds for sample. Our method can perform ancestral 
inference of 32,266 samples in one day while the SNPRelate software will take about 10 
days.  
3.4 Conclusion and discussion 
This chapter describes an efficient and accurate ancestral inference model using sequence 
data. The model belongs in the likelihood framework, and it extends the previous work 
(Yang et al.). Unlike the popular PCA method or the LASER method that are 




data in a joint likelihood model, and the maximum likelihood estimation step has the 
computational complexity of O(NM). This greatly reduces the computational cost (e.g. 
PCA method has O(N
3
) computational complexity). In addition to its efficiency, our 
method has good accuracy. Through extensive simulations and real data from a large-
scale genetic study, we have demonstrated the inferred ancestral origins are precise.  
Our method calculates ancestral locations in the likelihood maximization step. To obtain 
numerically reliable results, we applied the simplex method with random start points. In 
practice, we found this approach is insensitive to the start points and thus generates 
robust results. It is worth noting that there are other optimization procedures such as the 
BGFS method and L-BGFS method (Broyden 1970; Fletcher 1970; Kelley 1999). They 
use derivatives of the likelihood function to speed up convergence speed during 
optimizations. These methods may be faster. However, since the likelihood is not 
guaranteed to be convex, similar to simplex method, these approaches can be trapped in 
local maxima (Shanno and Phua 1980; Sekhon and Mebane 1998).  
Our inference method has wide applicability in sequencing studies. Because it only 
requires a genome-wide coverage higher than 0.001X (as shown in the simulation), it can 
provide global ancestral information using a wide range of sequencing experiment 
settings, such as targeted sequencing, exome sequencing and whole genome sequencing.  
The inferred ancestries are important in genetic association analysis, since they can be 
used to control population stratification caused by heterogeneous populations. For 
example, the ancestral locations have been shown to help discover rare disease-




shown the inferred ancestries of case and control samples can be matched to reduce 
spurious association.  
We describe how to obtain reference coordinates from an external reference panel. The 
advantage of this step is to ensure the inferred ancestral locations of sequence samples are 
placed in the same coordinates. When the external reference panel is unavailable, our 
method can be slightly modified from Equation 1 so that it can jointly infer the SNP 
gradients, SNP intercepts and ancestral locations of sequence samples. As  (   ) is a 
function of        and the        has unknown parameters    and   , the parameters’ 
space now has high dimensionality. The optimization procedure will need to iteratively 
optimize between gradients/intercepts (  and  ) and ancestral locations ( ), which is 
similar to (Yang et al. 2012). However, the inferred ancestral locations will not likely be 
in the same reference coordinates space where HGDP samples are utilized. 
As genetic studies are growing fast, we envision that researchers will aggregate huge 
amount of sequencing data and will face the so-called “big data” challenge. To tackle the 
data at this scale, we expect our method and its implementation can rapidly and 
accurately infer sample ancestries, which can be helpful in a wide range of genetic 
studies such as association studies. Our method described here has been implemented and 







3.5 Figures and tables 






Figure 3-2 Gradients of three markers and an example of joint likelihood surface 
(a-c) allele frequency for three markers, their gradients are:  
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Figure 3-3 Optimization using simplex method 
This figure illustrates how simplex method searches the maxima on the likelihood surface. 
The search path at the beginning is along the gradient direction, then it wiggles the search 






Figure 3-4 Ancestral inference of sequenced data using different depth and error rate 
632,907 single nucleotide variants of 938 Human Genome Diversity Project samples are 
used to simulate sequence data. Sequence error rates per base per read are set at 0.1%, 1% 
and 10%. The sequence depths are set at 0.1X, 1X and 5X.  The seven color legends 










Figure 3-5 Comparison between PCA method, LASER method and the likelihood method 
920 samples that are used in both AMD targeted sequencing project and previous 
International AMD Gene Consortium. We infer their ancestries using different methods. 
(Top) The Principal Components Analysis (PCA) method is applied on genome wide 
SNP data of the 920 samples. 
(Middle) The LASER method is applied on sequence data of these samples from the 
AMD targeted sequencing project. 
(Bottom) Our likelihood based method is applied on sequence data of these samples from 









Table 3-1 Accuracy using simulated sequence reads assuming base error of 0.01. 
632,907 single nucleotide variants of 938 Human Genome Diversity Project samples are 
used to simulate sequence data. Sequence error rate per base per read is set from 0.001 to 
0.1 and sequence depth is set from 0.001X to 50X. Pearson correlation between 
likelihood model-based ancestral coordinates and known principal component 




 0.001 0.002 0.005 0.01 0.02 0.05 0.1 
0.001  0.9573 0.9563 0.9571 0.9564 0.9502 0.9395 0.9136 
0.002  0.9781 0.9784 0.9775 0.9773 0.9774 0.9689 0.9567 
0.005  0.9904 0.9906 0.9896 0.9893 0.9885 0.9859 0.9788 
0.01  0.9942 0.9944 0.9945 0.9942 0.9937 0.9923 0.9879 
0.02  0.9962 0.9964 0.9962 0.9961 0.9960 0.9953 0.9925 
0.05  0.9975 0.9975 0.9976 0.9977 0.9975 0.9972 0.9956 
0.1 
 
0.9981 0.9980 0.9979 0.9980 0.9979 0.9979 0.9968 
0.2 
 
0.9982 0.9982 0.9982 0.9983 0.9982 0.9981 0.9971 
0.5 
 
0.9983 0.9983 0.9983 0.9983 0.9982 0.9983 0.9973 
1 
 
0.9984 0.9984 0.9983 0.9983 0.9983 0.9984 0.9972 
2 
 
0.9984 0.9984 0.9984 0.9984 0.9984 0.9983 0.9970 
5 
 
0.9983 0.9983 0.9983 0.9983 0.9983 0.9983 0.9961 
10 
 
0.9982 0.9983 0.9982 0.9982 0.9982 0.9982 0.9956 
20 
 
0.9982 0.9982 0.9982 0.9982 0.9982 0.9982 0.9961 
50 
 






Table 3-2 Accuracy using simulated sequence reads assuming base error of 0.001. 
632,907 single nucleotide variants of 938 Human Genome Diversity Project samples are 
used to simulate sequence data. Sequence error rate per base per read is set from 0.001 to 
0.1 and sequence depth is set from 0.001X to 50X. Pearson correlation between 
likelihood model-based ancestral coordinates and known principal component 




 0.001 0.002 0.005 0.01 0.02 0.05 0.1 
0.001  0.9582 0.9562 0.9579 0.9542 0.9519 0.9351 0.8877 
0.002  0.9773 0.9777 0.9785 0.9750 0.9722 0.9641 0.9414 
0.005  0.9907 0.9903 0.9894 0.9897 0.9881 0.9839 0.9718 
0.01  0.9943 0.9941 0.9938 0.9939 0.9929 0.9904 0.9817 
0.02  0.9963 0.9964 0.9962 0.9959 0.9957 0.9943 0.9872 
0.05  0.9975 0.9974 0.9972 0.9973 0.9973 0.9963 0.9901 
0.1  0.9978 0.9978 0.9978 0.9978 0.9978 0.9968 0.9912 
0.2  0.9980 0.9981 0.9980 0.9981 0.9980 0.9973 0.9914 
0.5 
 
0.9982 0.9981 0.9982 0.9982 0.9982 0.9973 0.9912 
1 
 
0.9982 0.9982 0.9982 0.9982 0.9982 0.9973 0.9904 
2 
 
0.9982 0.9982 0.9982 0.9983 0.9983 0.9972 0.9884 
5 
 
0.9983 0.9982 0.9982 0.9982 0.9982 0.9968 0.9770 
10 
 
0.9982 0.9982 0.9982 0.9982 0.9982 0.9968 0.9596 
20 
 
0.9982 0.9982 0.9982 0.9982 0.9982 0.9973 0.9678 
30 
 
0.9982 0.9982 0.9982 0.9982 0.9982 0.9977 0.9838 
50 
 
0.9982 0.9982 0.9982 0.9982 0.9982 0.9975 0.9904 
100 
 






Chapter 4 Improve genotype calling using external reference panel 
4.1 Abstract 
Next generation sequencing (NGS) enables more comprehensive researches of genetic 
variations at a fraction of costs of the traditional capillary sequencing. A key step in the 
NGS is to overcome sequence errors and generate a large amount of accurate genotype 
calls. A majority of genotype callers process sequence reads overlapping certain genomic 
locations, and estimate genotypes using this site-wise information. However, this method 
can be improved by incorporating linkage-disequilibrium (LD) information using 
external reference panels. Here, we propose an integrated workflow that can benefits 
from the ever growing high quality reference panels. In our simulation, this procedure is 
shown to have high variant discovery rates and improved accuracy. For example, the 
concordance can be improved from 86.1% to 91.0% in a sequence of 0.5X coverage, 
using a population-based genotype caller and our proposed LD-aware genotype caller 
(using a reference panel of 100 samples) respectively. Using the 1000 Genome Project 
data, our approach is shown to improve the genotype calls with realistic computational 
costs (genotype concordance improved to 93% using 100 samples). In all, we expect this 
imputation-based workflow can be applied in population-based sequencing experiments 





Genotype calling algorithms are improving over the time. The earliest approach to call 
genotypes used one sample at a time (Levy et al. 2007; Wheeler et al. 2008; Lupski et al. 
2010), which works relatively well for a small number of deeply sequenced genomes. 
Methods that examine single samples typically require very deep coverage of each 
genome to estimate accurate genomes (Bentley et al. 2008; Kim et al. 2009). Later 
genotype callers examine multiple samples together (Li et al. 2008; Li et al. 2009a; 
McKenna et al. 2010; Garrison and Marth 2012). This approach uses population 
information can improve genotype accuracy (e.g. for low coverage samples, accuracy 
improved from 80% to 87%, (Nielsen et al. 2011)). The most recent callers use linkage 
disequilibrium (LD)-information by examining haplotypes shared between study samples 
(Browning and Yu 2009; Li et al. 2009b; Le and Durbin 2011; Wang et al. 2013).  It is 
now clear that methods that use haplotype sharing information can greatly reduce error 
rates, particularly as the number of sequenced samples increases. With these methods, 
highly accurate genotypes can be obtained even at relatively low depths, reducing the 
cost per sequenced sample. For example, in the 1000 Genomes Project pilot, with 179 
sequenced samples sequenced at 2X-6X depth, the estimated error rate at heterozygous 
sites was >70% (The 1000 Genomes Project Consortium 2010). In the 1000 Genomes 
Phase 1 paper, with 1092 sequenced samples sequenced at 2X-6X depth, the estimated 
error rate at heterozygous sites decreased to >95% (The 1000 Genomes Project 
Consortium et al. 2012).   
Models that use haplotype sharing describe each sample as an imperfect mosaic of the 




foundation to imputation algorithms (Li et al. 2009b; Marchini and Howie 2010).  This 
imperfect mosaic can be modeled using Hidden Markov Models (HMMs) (Browning 
2006; Marchini et al. 2007; Li et al. 2010; Hu et al. 2013).  
It is clear that, in large studies, combining multi-sample calling to discover variant sites 
with haplotype sharing analysis to estimate accurate genotypes is now the approach of 
choice. However, for small studies, the benefits of haplotype sharing approaches are 
more limited and obtaining good results often still requires deep sequencing of each 
sample. In principle, many of these small studies could benefit from analyses that 
combine information on sequenced samples with information on previously estimated 
haplotypes from other studies. In this chapter, we evaluate the benefits of external 
reference panels in the analysis of low-coverage sequence data from relatively small 
studies. We evaluate the genotype accuracy for reference panels of various sizes using 
both simulated sequence data and data from the 1000 Genome Project. Our results 
demonstrate that utilizing a large reference panel in the analysis of low pass sequence 
data for a single sample aids in both variant discovery and genotype accuracy. Our work 
suggests cost-effective sequencing strategies that leverage the growing number of 
publicly available reference panels. 
4.3 Materials and methods 
4.3.1 Models 
We illustrate a HMM model and its application in Figure 4-1. In Figure 4-1 (a), following 
previous work (Li et al. 2011), we denote   as a genomic position along a chromosome 




4-1 (b)). The transition probability  (       )  corresponds to the probability of 
recombination (or switching) from state    to state      . The emission probability 
 (  |  )  represents the probability of observing a genotype    given the underlying 
template specified by state    . In GWAS studies,    often remains unobserved, for 
example, as a result of genotyping array design.  
In practice we use the software beagle to fit the HMM model (Browning 2006). The 
variable-length Markov Chain model implemented in beagle is an extension of the HMM 
model described above and is appealing in terms of high computation efficiency and high 
imputation accuracy (Browning 2006). Here the results of beagle represent the 
performance of the LD-aware genotype callers.   
The goal of applying a HMM model is to combine haplotype information across samples 
(Figure 4-1 (b)) to infer the untyped genotypes or to provide a prior distribution for low 
pass genotypes (Figure 4-1 (c)). Utilizing external reference panels of high quality 
haplotypes, we expect the improved interpretations of sequenced data for most studies. 
4.3.2 Simulation design 
Simulating true genotypes using coalescent theory 
We simulated 15,000 haplotypes using a coalescent model (Figure 4-3) and the program 
ms (Hudson 2002), each one million base pairs long. The demographic model was 
consistent with European demographic history (Adams and Hudson 2004; Novembre et 
al. 2008), which includes an ancestral bottleneck followed by more recent population 




Our model assumes an ancestral population with an effective population size of    
      , where an instantaneous bottleneck event 3,000 generations in the past reduced 
population size to                 . Then, our simulations assume that this population 
simultaneously split into present day populations 500 generations before the present. 
Following the divergence from the ancestral population, the present-day populations 
underwent recent exponential growth, each growing to a present day effective population 
size of         
  over 400 generations. We assume equal, symmetric migration rates 
between the sub-populations with a per-haplotype, per-generation migration rate of 
       . We also assume a per-basepair, per-generation mutation rate of           
and a recombination rate equivalent to 1cM/Mb. We sampled 5,000 haplotypes from each 
of the present day subpopulations. 
Simulating sequence data and reference panels 
After coalescent simulation, we randomly paired haplotypes to assemble 2,500 
individuals within each population (Figure 4-4). We selected 100 of these as our test data 
set. To mimic the next generation sequencing technology, we simulated sequence reads 
with length 100 base pairs and 0.1% base error rate. We set the number of sequence reads 
such that the average sequence depths equal to 0.5X, 1X, 2X, 4X, 6X, 12X and 30X. 
Following the simulation workflow (Figure 4-4), we align sequence reads using BWA (Li 
and Durbin 2009). We used the haplotypes of the remaining individuals as a reference 
panel. As the coalescent model provides their true haplotypes, we did not model 





We set out to explore the utility of the reference. After excluding the 100 test samples, 
the remaining 7,400 samples were randomized and organized into reference panels of 
different sizes including between 100 and 2400 individuals. First, we considered 
reference panels including samples from one population. Then the reference panels are 
selected from the same population as the test data. Second, we considered reference 
panels including samples from different populations. We chose 50% reference samples 
from the same population as the test samples, and 25% reference samples from each of 
the other two populations.  
These simulations mimic real sequencing experiments in which a limited number of 
samples is sequenced but where large sets of reference samples might be available by 
aggregating information across prior sequencing studies. To explore optimal strategies 
for obtaining high quality genotype calls for the test samples, we benchmark various sizes 
of the reference panels, matching between the reference panels and samples being studied, 
the sequencing depths and the choice of genotype callers. 
4.3.3 The 1000 Genome Project data 
In real data examples, we use European samples from the 1000 Genome Project to 
evaluate sequence experiment design. In the Phase 1 release, there are 330 European 
ancestry samples drawn from five populations: 184 Utah residents (CEPH) with northern 
or western European ancestry (CEU), 105 Finnish in Finland (FIN), 107 British in 
England and Scotland (GBR), 162 Iberian in Spain (IBS) and 112 Toscani in Italia (TSI).  
We randomly select 10 unrelated samples from CEU population as test samples and use 




with mean depth of 5x calculated by QPLOT (Li et al. 2013). We assemble the reference 
panels in two ways. In the first reference panel, the reference panel included 50 CEU 
samples; in the second reference panel, it included the same 50 CEU samples as well as 
25 FIN samples and 25 GBR samples. There were no overlapping samples between test 
data sets and reference panels.  
4.3.4 Genotype calls 
We evaluate three types of algorithms to call genotypes. The first genotype caller, 
implemented in glfSingle, infers genotypes one sample at a time. The second genotype 
caller, implemented in glfMultiples, infers genotypes examining all sequenced samples 
jointly (100 samples in the simulations, 10 samples in the 1,000 genomes project 
analysis). The third genotype caller, implemented in beagle (Browning and Yu 2009), is a 
LD-aware genotyping algorithm using both sequence reads of all individuals and an 
external reference panel. Under this setting, we prepare genotype likelihoods for all sites 
in the external reference panel, and then estimate genotypes using both reference panel 
haplotypes and sequence information for each sample. The version of glfSingle and 
glfMultiples is a compiled executable dated in June 2010, and beagle is version 3.3.1 (26 
Dec 2010).  
4.3.5 Evaluation 
We compare these genotype callers in discovery rate and concordance. We define the 
discovery rate as the fraction of detected variant sites (those called by various genotype 
callers) among all true variants sites of the test samples (Figure 4-2). The discovery rate 




often the case that rare variants cannot be detected (e.g. low sequence depths). For 
simulations, the coalescent model provides true genotypes. For real data, we use OMNI 
genotype array data as the gold standard (The 1000 Genomes Project Consortium 2010). 
Similarly, we define the concordance rate as the fraction of correct genotype calls of all 
variants (Figure 4-2). In simulations, as reference panels have different sizes, we select 
variants that are located on all reference panels. Then the concordance for each sample is 
the fraction of correct estimated genotypes at these variant sites. In the real data, we use 
the genotypes typed on the OMNI chips as gold standard. The concordance can be close 
to one at rare variant sites even when their genotypes are wrongly called as reference 
genotypes. However, we compare this statistic across different simulation settings, so it is 
still informative to identify a good genotype caller.  
Ideally, a good genotype caller should simultaneously achieve high discovery rate and 
high concordance rate, meaning accurate genotype calls at abundant polymorphic sites. 
To evaluate the three genotype callers, we consistently calculate these two measurements 
in a wide range of settings.  
4.4 Results 
4.4.1 Evaluation using simulated data 
Coalescent simulation 
Using a coalescent model, we obtained 88,550 variant sites among 7,500 simulated 
samples. Stratified by minor allele frequency, we observed an excessive number of rare 




0.1% and 0.2%, 1,145 SNPs between 0.2% and 0.5%, 734 SNPs between 0.5% and 1%, 
610 SNPs between 1% and 2%, 791 SNPs between 2% and 5%, 2,963 SNPs between 5% 
and 50%). To measure the difference between populations, we used vcftools to calculate 
Fst (Weir and Cockerham 1984; Danecek et al. 2011) statistics. In our simulation, we 
found the Fst value of 0.007, which is comparable to Fst between different European 
populations (Nelis et al. 2009; Tian et al. 2009). 
Test samples are randomly drawn from one population 
We randomly selected 100 samples from one of the three populations as test samples. 
Among all samples, there are 7,180 polymorphic sites (1,808 SNPs with minor allele 
frequency less than 0.1%, 222 SNPs between 0.1% and 0.2%, 465 SNPs between 0.2% 
and 0.5%, 449 SNPs between 0.5% and 1%, 504 SNPs between 1% and 2%, 769 SNPs 
between 2% and 5%, 2,963 SNPs between 5% and 50%). Depending on the sequence 
depths set from 0.5X to 30X, we obtained from 10,000 to 600,000 paired reads per 
sample. Using a single sample based genotype caller, glfSingle, we obtained 2,407 (0.5X) 
to 7,173 (30X) variant per sample. Using a population based genotype caller, 
glfMultiples, we obtained 3,099 (0.5X) to 7,172 (30X) variants among the same 100 
samples. As the above genotype callers do not utilize any external reference panel, we 
will then evaluate how to incorporate this information. 
When reference samples are drawn from the same population 
We first explored how the size of the reference panel affects the genotype calling quality 
in one population. In Figure 4-5, glfSingle and glfMultiples do not use reference 




reference panel size. Noticeably, the single sample based method provides the worst in 
discovery rate. In contrast, imputation-based methods use the reference panels to help 
identify variant sites. The discovery rate for the imputation method improved upon that 
for methods that used the test samples alone (mean discovery rate for beagle: 98.84%) 
compared to other methods. Figure 4-5 also shows that the imputation-based method 
performs best when the largest reference panel is used. When the reference panel 
increased from 100 samples to 2,400 samples, the reference polymorphic markers 
increased from 7,006 SNPs to 34,771 SNPs. The reference panels with denser SNP 
markers can help discover more variants of the test samples.  In terms of overall 
concordance on a common set of 7,005 SNPs, imputation-based software also had 
advantages comparing to other methods and it performed better when reference panel size 
increased as well (e.g. at 0.5x depth, glfSingle: 84.4%; glfMultiples 86.1%; beagle using 
100 reference samples:  90.9%; beagle using 800 reference samples = 94.0%).  
Imputation-based genotype analyses also outperformed other methods when we 
performed comparisons stratified by allele frequencies. In Figure 4-6, we separated 
variants into 6 minor allele frequency bins and evaluated performance in each bin. When 
examining discovery rates, glfSingle had poor power to detect variants with minor allele 
frequency between 0.1% and 0.2% (discovery rate: 50.1%) while imputation methods 
(beagle) outperformed population-based analysis of test samples when the reference 
panel size was larger than 200 (discovery rate: 77.5% using 200 reference samples and 
100.0% using 400 or more reference samples versus 46.4% using the test samples alone 
and a population based caller like glfMultiples). When evaluating concordance, we also 




outperform other genotype callers when MAF was larger than 1% (Figure 4-6). For 
example, at sequence depth of 4x, the concordance of glfSingle and glfMultiples is 98.01% 
and 99.02% for the low frequency variants (MAF between 1% and 2%). Using the LD-
aware genotyping method, beagle can achieve 99.4% accuracy using only 100 reference 
samples. When the reference panel increases, the accuracy will increase as well. We also 
notice imputation-base method has more prominent heterozygous accuracy. Evaluated 
using 1% to 2% variants again, the accuracy for glfSingle, glfMultiples and beagle (100 
reference sample) in the heterozygous sites are 44.0%, 74.6% and 79.8% respectively. 
When imputation panel consists of the multiple populations 
We then set out to investigate reference panels with multiple populations. In Table 4-1, 
we compared a reference panel of the same population to a reference panel of three 
populations with 2:1:1 ratio. Under both settings, imputation-based genotype callers 
performed better with larger reference panels. For example, when 100 reference samples 
of the same population served as reference and 100 tests samples were sequenced at 0.5X, 
imputation-based produced 90.73% concordance. When reference samples increased to 
800, the concordance rate also increased to 93.67%. We observed that, when the 
reference panel size is kept constant, the imputation-based methods performed better 
when the reference panel contained more individuals from the same population as test 
samples.  
4.4.2 Evaluation using the 1000 Genome Project samples 
We then evaluated genotype callers using two reference panels from 1000 Genome 




based caller, glfMultiples, only discovered 92.7% of the variants and had concordance of 
82.8% for all variants. Our imputation-based methods improved both the discovery rate 
and concordance. Using 50 CEU reference samples and 100 European reference samples 
(50 CEU, 25 FIN and 25 GBR), the overall concordance was 92.1% and 92.3% 
respectively. We also measure the computational times, 55 minutes and 114 minutes, for 
the two scenarios respectively. 
4.5 Discussion 
Here, we evaluate imputation-based genotype callers using external reference panels. The 
reference panel summarizes population level haplotype information and helps improve 
genotype calls. Using simulations and 1000 Genome Project data, we have shown that 
imputation-based methods can outperform non-LD aware callers in terms of the 
concordance and the discovery rate.  
Our results directly inform the analysis of future genetic studies. As we expect large-scale 
sequencing experiments to become more popular, large numbers of high quality 
haplotypes will soon become available. Our work shows that these can serve as a 
resource to improve analysis of newly sequenced samples, reducing sequencing costs and 
thus speeding up sequencing based genetic researches. Incorporating reference panels can 
improve the efficiency of lower coverage sequencing. In our simulation, with 4x average 
sequencing coverage, the genotype concordance can be improved from 96.8% to 99.6% 
using a reference panel of 2400 samples. Specifically, the overall concordance at the 




The advantage of the reference panel is to provide high quality population-level 
haplotype information. At variant sties, the information can improve genotype calls due 
to precise allele frequency prior of the variant or the haplotype stretch around the variant 
sites. We have shown that by modeling LD near the variant sites, the genotype calling 
can be improved across variants of all allele frequencies. However, we also notice that 
some variants are unique in the sequence samples but not in the reference panel. These 
variants cannot be improved by our method. Another limitation emerges when the 
reference panel size increase. The computational cost in a standard HMM model has 
quadratic computational complexity. When scaling up to a whole genome low coverage 
sequencing experiments, the computational time can consume 50-100 hours for 100 low 
coverage sequence samples using 50-100 reference samples. When thousands of 
reference samples are used as a reference panel, the computational time may not be 
neglected. 
Large panel of haplotypes is a useful resource, and there have been growing interests in 
building and applying it. Previously, the major histone complex (MHC) haplotype 
consortium deepen the understanding our understanding of the common variation in the 
MHC region (Horton et al. 2008). In the recent years, there is another haplotype 
consortium (O'Connell et al.) in which thousands of sequence based haplotypes can be 
utilized in improving genotype calls, the same goal as we described here. Therefore, we 





4.6 Figures and tables  
Figure 4-1 Illustration of HMM model using external reference panel 
 (a) Hidden Markov Model where S are the hidden states and G represent observed 
genotypes; (b) Reference haplotypes. Each haplotype represents a possible state, and can 
be selected to update sample genotypes; (c) Sample with uncertain genotypes and 







Figure 4-2 Definition of discovery rate and concordance 
Discovery rate is a measurement of sensitivity, which is defined as the fraction of 
detected variant sites among all variant sites. In (a), we illustrate four genomic locations 
of three samples. The letter “V” without brackets denotes a sample carries a variant 
detected by a genotype caller, and the letter “V” with bracket denotes the variant that is 
not detected. In (b), we illustrate a summary of variant sites of the three samples. The star 
symbols indicate detected variant sites, and the yellow boxes denote all true variant sits 
among three samples. We can define discovery rate as 2 (counts of stared area) divided 






Genotype concordance is a measurement of accuracy, which is defined as the fraction of 
correctly estimated genotypes among all estimated genotypes. HomRef: homozygous 






Figure 4-3 Coalescent simulations of European haplotypes 
Demographic model for simulated European populations. The demographic model 
includes an ancient population bottleneck, recent exponential growth, differentiation and 
migration. The model parameters were calibrated to mimic populations sampled in 









Figure 4-4 Simulation workflow 
In simulation, we first simulation genotypes for test samples and reference samples. For 
test samples, we perform standard sequence simulations (details described in 4.3.2). For 
reference samples, we choose all or part of them as reference panels of various sizes. 






Figure 4-5 Marginal genotype calling accuracy. 
Genotype accuracy is evaluated by concordances and discovery rates. At various 
sequence depths (0.5X, 1X, 2X, 4X, 6X, 12X and 30X), we evaluate three approaches: 
glfSingle, glfMultiples and beagle. In evaluating beagle, we choose different reference 












Figure 4-6 Genotype calling quality stratified by MAF at various depths. 
We evaluate genotype concordance and discovery rate in various simulation settings. The 
evaluations are stratified by allele frequency bins: 0-0.1%, 0.1-0.2%, 0.2-0.5%, 0.5-1%, 
1-2%, 2-5%, 5-50%. For concordance, we chose 0.5X, 1X, 2X and 4X, as higher depths 
have similar concordance as in the 4X settings. For discovery rates, we choose sequence 
depths at 0.5X, 1X, 2X, 4X, 6X, 12X and 30X. We evaluate three approaches: glfSingle, 
glfMultiples and beagle. In evaluating beagle, we choose different reference panel sizes 















Table 4-1 Comparison of genotype calling quality using different reference panel 
We compare two settings of reference panels: (Up) the reference panel consists of one 
population; (Down) the reference panel consists of three populations (counts of 
population size is 2:1:1). We evaluate the concordances and discovery rates at various 
sequence depths (0.5X, 1X, 2X, 4X, 6X, 12X and 30X). The imputation-based approach, 
beagle, is used in this simulation (50 iterations) and we choose different reference panel 







Same Population in Reference Panel 
  
  Reference Panel Size   
  100 200 400 800 1200 2400 
Sequence Depth 0.5 0.9094 0.9266 0.9385 0.9433 0.9428 0.9395 
1 0.9507 0.9607 0.9694 0.9719 0.9716 0.9716 
2 0.9751 0.9791 0.9852 0.9873 0.9880 0.9885 
4 0.9886 0.9912 0.9944 0.9955 0.9960 0.9961 
6 0.9941 0.9958 0.9972 0.9979 0.9981 0.9982 
12 0.9990 0.9993 0.9994 0.9995 0.9996 0.9996 
30 0.9998 0.9998 0.9998 0.9998 0.9998 0.9998 
Discovery Rate 0.9780 0.9875 0.9905 0.9921 0.9928 0.9941 
Different Populations in Reference Panel 
  
  Reference Panel Size   
  100 200 400 800 1200 2400 
Sequence Depth 0.5 0.9073 0.9177 0.9299 0.9367 0.9371 0.9340 
1 0.9469 0.9581 0.9648 0.9686 0.9702 0.9683 
2 0.9736 0.9791 0.9838 0.9868 0.9880 0.9867 
4 0.9885 0.9919 0.9940 0.9957 0.9960 0.9954 
6 0.9938 0.9957 0.9971 0.9979 0.9981 0.9978 
12 0.9984 0.9993 0.9994 0.9996 0.9996 0.9995 
30 0.9992 0.9998 0.9998 0.9998 0.9998 0.9998 






Table 4-2 Evaluation of genotyping calling using the 1000 Genome Project data 
We evaluate the genotype callers (glfMultiples and beagle) using the 1000 Genome 
Project data. We show the concordance and discover rate stratified by different minor 
allele frequency bins (MAF are obtained from the 1000 Genome Project Phase 1 release 
(2011/05/21)). When evaluation uses beagle, we let beagle iterate 50 times. 
 
  glfMultiples beagle 
   50 100 
MAF 0.002 - 0.01 0.8889 0.7143 0.8125 
0.01 - 0.02 0.9801 0.9472 0.9332 
0.02 - 0.05 0.9474 0.9054 0.9029 
0.05 - 0.5 0.8269 0.9287 0.9308 
(all) 0.8281 0.9206 0.9227 







Chapter 5 Summary and Discussion 
Next-generation sequencing technology has improved fast over the past several years. It 
enables researchers to study a broad range of genetic questions: from characterization of 
DNA and RNA variations, to metagenomics and transcriptomics in a more systematic 
manner. However, this new technology brings up new challenges. For example, due to 
the long processing time and the high error rate of NGS technology, it is challenging to 
use traditional methods to analyze the mass amount of imperfect sequences. To help 
overcome these challenges in the sequence era, my thesis includes three chapters. Each 
chapter focuses on one useful statistical method that can efficiently handle large amount 
of sequence data, extend related statistical genetics questions, and produce accurate and 
meaningful results.  
Chapter 2 focuses on ancestral inference of sequence samples in an age-relate macular 
degeneration association study. While the ancestral inference question using genotyping 
array has been widely studied (Price et al. 2006), the commonly used principal 
components analysis (PCA) can infer global ancestries or fine-scale European ancestries. 
However, three factors perplex this specific question: (1) coverage of sequence reads is 
not uniformly distributed, even in the targeted sequence region; (2) per-base error rate in 
the sequence reads is higher than in genotype data; (3) the majority of sequence data is 
close to known disease susceptible loci. These three problems are barriers to applying the 




Thus, to address these limitations, we have developed the LASER (Locating Ancestries 
using Sequence Reads) method, which does not require genome-wide sequence coverage. 
It robustly incorporates error in the estimation procedure, and utilizes both on-target and 
off-target sequence reads to avoid the unclear influence of the disease susceptible loci. 
The LASER has enabled us to identify ancestries of sequenced samples in the Age-
related Macular Degeneration (AMD) project as well as in the NHLBI exome sequencing 
project (Fu et al. 2013). We matched sets of 2,268 cases and 2,268 controls and focus on 
coding variants with deep (minimum 10X) coverage. Subsequent association analysis 
identified two strongly associated variants, one in the CFH gene (control frequency = 
0.02%, exact P-value = 2.91x10-6, OR = 23.11) and another in the C3 gene (control 
frequency = 0.40%, exact P-value = 2.73x10-4, OR = 2.68).  This discovery will help us 
understand the disease etiology and my help treat this disease more effectively in the 
future. Although the method still required much computation time, it represents a 
significant improvement over the PCA method in terms of ancestral inference from the 
targeted sequencing data. 
As an extension to the work in Chapter 2, we investigated a likelihood model in Chapter 
3 that can efficiently infer ancestral origins using both genotype data and sequence data. 
This work utilizes the genetic marker gradients, which describe how allele frequency 
changes geographically. We extensively evaluated this model using simulated genotypes 
and sequence data and obtained accurate ancestral locations at modest computation cost. 
We further evaluated the model using target-sequence data in an AMD study. The 
method yielded comparable results to the PCA method, but uses a fraction of the 




to a wide range of genetic studies such as “the big data” problem which can include a 
large number of sequenced individuals. This method could even potentially be 
commercially available to the public interested in understanding their ancestries.  
Besides the ancestral inference questions, in Chapter 4, we advocate a genotyping calling 
strategy using the ever-growing reference panel. Currently, sequence technology is 
becoming increasingly adapted so that more genetic studies will benefit from it. 
Therefore, the size of publicly available reference panels can be expected to grow. Our 
strategy showed that these reference panels can be incorporated in the sequence 
genotyping procedure using a Hidden Markov Model (HMM). This finding can be 
helpful for researchers conducting sequence experiments and seeking to improve existing 
genotyping results. 
Building on this dissertation, there are several aspects to explore in the future. Our 
likelihood-based ancestral inference method has been evaluated on world-wide 
populations using the Human Genome Diversity Project (HGDP) data set. To study a 
finer-scale population structure, it will be interesting to apply this method on European 
populations. We are in the process of applying the Population Reference Sample 
(POPRES) data set which provides genotype data of European populations. When this 
data set becomes available, we expect further evaluations and refinements of our method.  
Our improved imputation strategy can produce more accurate genotypes. We can then 
perform association tests. We have explored a Genetic Random Field (GRF) based 
method based on a novel alternative hypothesis, which models genotypes as random 




shown potentially interesting outcomes, and we can combine these results with the 
imputation procedure to closely study disease etiology. 
In summary, this dissertation includes ancestral inference algorithms and imputation-
based genotyping strategies. These are well suited for next-generation sequence studies as 
they are accurate and efficient compared to a wide range of existing work. Specifically, 
the ancestral inference algorithm is useful for genetic association studies to alleviate the 
so-called population stratification problem. Furthermore, the imputation strategy is 
widely applicable to researchers hoping to improve genotyping from sequence data. We 
envision more sequencing experiment will be conducted in the medical genetics fields. 
We expect that our methods play an essential role in various downstream analyses, and 
we hope to extend these methods to a broader range of applicable fields. In all, it can be 
expected that our statistical methods applied in next generation sequence data will greatly 
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